| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.938 | 0.001 | 0.938 | Tyrosine 3 hydroxylase inhibitor | 0.806 0.002 DBMET00785 0.737 0.002 DBMET03313 0.55 0.003 DBMET00637 0.886 0.001 DBMET00703 0.706 0.002 DBMET00704 0.51 0.004 DBMET03314 0.518 0.004 DBMET00784 0.51 0.004 DBMET03315 | ||
| 0.849 | 0.001 | 0.849 | Glutamate decarboxylase inhibitor | 0.35 0.003 DBMET00785 0.364 0.003 DBMET03313 0.266 0.004 DBMET00637 0.509 0.002 DBMET00703 0.217 0.005 DBMET00704 0.546 0.002 DBMET03314 0.073 0.051 DBMET03316 0.183 0.008 DBMET00784 0.546 0.002 DBMET03315 | ||
| 0.706 | 0.008 | 0.781 | Cholesterol antagonist | 0.457 0.039 DBMET00785 0.781 0.004 DBMET03313 0.493 0.034 DBMET00637 0.619 0.016 DBMET00703 0.413 0.047 DBMET00704 0.459 0.039 DBMET03314 0.679 0.01 DBMET03316 0.744 0.005 DBMET00784 0.459 0.039 DBMET03315 | DBMET03313 | |
| 0.629 | 0.002 | 0.629 | Histidine decarboxylase inhibitor | 0.431 0.004 DBMET00785 0.279 0.007 DBMET03313 0.382 0.004 DBMET00637 0.618 0.002 DBMET00703 0.38 0.004 DBMET00704 0.327 0.005 DBMET03314 0.069 0.052 DBMET03316 0.159 0.018 DBMET00784 0.327 0.005 DBMET03315 | ||
| 0.604 | 0.002 | 0.669 | Phenylalanine 4-hydroxylase inhibitor | 0.622 0.002 DBMET00785 0.329 0.004 DBMET03313 0.315 0.004 DBMET00637 0.669 0.002 DBMET00703 0.331 0.004 DBMET00704 0.669 0.002 DBMET03314 0.097 0.027 DBMET00784 0.669 0.002 DBMET03315 | DBMET03315 | |
| 0.601 | 0.019 | 0.719 | Aldehyde oxidase inhibitor | 0.686 0.009 DBMET00785 0.719 0.007 DBMET00637 0.669 0.011 DBMET00703 0.702 0.008 DBMET00704 0.669 0.011 DBMET03314 0.669 0.011 DBMET03315 | DBMET00637 | |
| 0.607 | 0.03 | 0.815 | Transcription factor NF kappa B inhibitor | 0.528 0.04 DBMET00785 0.466 0.05 DBMET03313 0.455 0.052 DBMET00637 0.605 0.031 DBMET00703 0.58 0.034 DBMET00704 0.502 0.044 DBMET03314 0.815 0.012 DBMET03316 0.431 0.057 DBMET00784 0.502 0.044 DBMET03315 | DBMET03316 | |
| 0.597 | 0.028 | 0.766 | Cyclophilin D inhibitor | 0.324 0.143 DBMET00785 0.579 0.031 DBMET03313 0.403 0.089 DBMET00703 0.442 0.07 DBMET03314 0.766 0.009 DBMET03316 0.488 0.054 DBMET00784 0.442 0.07 DBMET03315 | DBMET03316 | |
| 0.572 | 0.028 | 0.572 | 15-Lipoxygenase inhibitor | 0.255 0.161 DBMET00785 0.499 0.041 DBMET03313 0.452 0.053 DBMET00637 0.334 0.109 DBMET00703 0.277 0.145 DBMET00704 0.349 0.1 DBMET03314 0.406 0.072 DBMET00784 0.349 0.1 DBMET03315 | ||
| 0.544 | 0.006 | 0.72 | Peroxidase inhibitor | 0.639 0.004 DBMET00785 0.316 0.034 DBMET03313 0.535 0.007 DBMET00637 0.654 0.004 DBMET00703 0.556 0.006 DBMET00704 0.72 0.003 DBMET03314 0.72 0.003 DBMET03315 | DBMET03315 | |
| 0.542 | 0.005 | 0.542 | Growth hormone agonist | 0.373 0.02 DBMET00785 0.411 0.014 DBMET03313 0.134 0.102 DBMET00637 0.341 0.025 DBMET00703 0.306 0.031 DBMET00704 0.231 0.048 DBMET03314 0.379 0.019 DBMET00784 0.231 0.048 DBMET03315 | ||
| 0.532 | 0.01 | 0.791 | Superoxide dismutase inhibitor | 0.708 0.004 DBMET00785 0.671 0.005 DBMET03313 0.559 0.009 DBMET00637 0.791 0.003 DBMET00703 0.747 0.004 DBMET00704 0.54 0.01 DBMET03314 0.657 0.005 DBMET00784 0.54 0.01 DBMET03315 | DBMET00703 | |
| 0.542 | 0.022 | 0.542 | Immunosuppressant | 0.34 0.092 DBMET00785 0.462 0.044 DBMET03313 0.373 0.075 DBMET00637 0.326 0.1 DBMET00703 0.311 0.108 DBMET00704 0.302 0.114 DBMET03314 0.54 0.023 DBMET03316 0.437 0.051 DBMET00784 0.302 0.114 DBMET03315 | ||
| 0.501 | 0.004 | 0.798 | 5 Hydroxytryptamine uptake stimulant | 0.798 0.001 DBMET00785 0.248 0.083 DBMET03313 0.514 0.004 DBMET00637 0.66 0.002 DBMET00703 0.786 0.001 DBMET00704 0.577 0.003 DBMET03314 0.198 0.155 DBMET03316 0.215 0.124 DBMET00784 0.577 0.003 DBMET03315 | DBMET00785 | |
| 0.468 | 0.001 | 0.468 | DOPA decarboxylase inhibitor | 0.333 0.002 DBMET00785 0.265 0.003 DBMET03313 0.315 0.002 DBMET00637 0.403 0.001 DBMET00703 0.271 0.003 DBMET00704 0.22 0.005 DBMET03314 0.127 0.038 DBMET03316 0.177 0.011 DBMET00784 0.22 0.005 DBMET03315 | ||
| 0.459 | 0.034 | 0.859 | 5 Hydroxytryptamine release stimulant | 0.853 0.003 DBMET00785 0.61 0.014 DBMET00637 0.707 0.007 DBMET00703 0.859 0.002 DBMET00704 0.624 0.012 DBMET03314 0.479 0.031 DBMET03316 0.624 0.012 DBMET03315 | DBMET00704 | |
| 0.433 | 0.026 | 0.496 | Vasodilator, coronary | 0.426 0.028 DBMET00785 0.203 0.179 DBMET03313 0.306 0.083 DBMET00637 0.455 0.022 DBMET00703 0.486 0.017 DBMET00704 0.496 0.016 DBMET03314 0.485 0.018 DBMET03316 0.25 0.135 DBMET00784 0.496 0.016 DBMET03315 | DBMET03315 | |
| 0.453 | 0.049 | 0.594 | Histamine release inhibitor | 0.461 0.045 DBMET00785 0.4 0.076 DBMET03313 0.432 0.059 DBMET00637 0.477 0.037 DBMET00703 0.43 0.06 DBMET00704 0.579 0.012 DBMET03314 0.594 0.011 DBMET03316 0.296 0.126 DBMET00784 0.579 0.012 DBMET03315 | DBMET03316 | |
| 0.419 | 0.017 | 0.419 | Pyruvate kinase inhibitor | 0.244 0.063 DBMET00785 0.147 0.118 DBMET03313 0.306 0.046 DBMET00637 0.388 0.023 DBMET00703 0.25 0.061 DBMET00704 0.388 0.023 DBMET03314 0.388 0.023 DBMET03315 | ||
| 0.426 | 0.031 | 0.426 | Lipoxygenase inhibitor | 0.234 0.111 DBMET00785 0.188 0.153 DBMET03313 0.384 0.041 DBMET00637 0.288 0.077 DBMET00703 0.266 0.09 DBMET00704 0.349 0.051 DBMET03314 0.349 0.051 DBMET03315 | ||
| 0.419 | 0.049 | 0.64 | Vasodilator, peripheral | 0.398 0.056 DBMET00785 0.461 0.037 DBMET00637 0.465 0.036 DBMET00703 0.441 0.043 DBMET00704 0.64 0.012 DBMET03314 0.48 0.032 DBMET03316 0.64 0.012 DBMET03315 | DBMET03315 | |
| 0.37 | 0.006 | 0.37 | GABA C receptor agonist | 0.265 0.012 DBMET00785 0.099 0.068 DBMET03313 0.236 0.015 DBMET00637 0.255 0.013 DBMET00703 0.119 0.051 DBMET00704 0.182 0.024 DBMET03314 0.182 0.024 DBMET03315 | ||
| 0.382 | 0.022 | 0.499 | Interleukin agonist | 0.448 0.013 DBMET00785 0.298 0.049 DBMET00637 0.452 0.013 DBMET00703 0.398 0.019 DBMET00704 0.499 0.009 DBMET03314 0.405 0.018 DBMET03316 0.499 0.009 DBMET03315 | DBMET03315 | |
| 0.408 | 0.053 | 0.408 | Thyroid hormone antagonist | 0.278 0.105 DBMET00703 | ||
| 0.364 | 0.01 | 0.53 | Peptidyltransferase inhibitor | 0.282 0.032 DBMET00785 0.289 0.029 DBMET03313 0.204 0.094 DBMET00637 0.271 0.038 DBMET00703 0.253 0.049 DBMET00704 0.53 0.003 DBMET03314 0.406 0.006 DBMET03316 0.257 0.046 DBMET00784 0.53 0.003 DBMET03315 | DBMET03315 | |
| 0.361 | 0.013 | 0.446 | Phospholipase C inhibitor | 0.363 0.013 DBMET00785 0.446 0.008 DBMET03313 0.232 0.029 DBMET00637 0.385 0.011 DBMET00703 0.239 0.027 DBMET00704 0.254 0.024 DBMET03314 0.181 0.06 DBMET03316 0.26 0.023 DBMET00784 0.254 0.024 DBMET03315 | DBMET03313 | |
| 0.375 | 0.033 | 0.743 | Free radical scavenger | 0.434 0.024 DBMET00785 0.303 0.051 DBMET03313 0.594 0.009 DBMET00637 0.474 0.019 DBMET00703 0.438 0.023 DBMET00704 0.377 0.033 DBMET03314 0.743 0.005 DBMET03316 0.198 0.099 DBMET00784 0.377 0.033 DBMET03315 | DBMET03316 | |
| 0.412 | 0.071 | 0.591 | 5 Hydroxytryptamine release inhibitor | 0.58 0.014 DBMET00785 0.461 0.047 DBMET00637 0.591 0.012 DBMET00703 0.561 0.017 DBMET00704 0.555 0.018 DBMET03314 0.535 0.023 DBMET03316 0.555 0.018 DBMET03315 | DBMET00703 | |
| 0.363 | 0.029 | 0.698 | Psychostimulant | 0.663 0.005 DBMET00785 0.195 0.083 DBMET00637 0.619 0.005 DBMET00703 0.628 0.005 DBMET00704 0.698 0.004 DBMET03314 0.192 0.085 DBMET03316 0.698 0.004 DBMET03315 | DBMET03315 | |
| 0.324 | 0.004 | 0.324 | Creatine kinase inhibitor | 0.279 0.004 DBMET00785 0.189 0.012 DBMET03313 0.245 0.006 DBMET00637 0.143 0.027 DBMET00703 0.159 0.02 DBMET00704 0.247 0.005 DBMET03314 0.247 0.005 DBMET03315 | ||
| 0.397 | 0.083 | 0.561 | Calcium channel L-type activator | 0.4 0.081 DBMET00785 0.426 0.065 DBMET00637 0.38 0.095 DBMET00703 0.378 0.097 DBMET00704 0.561 0.011 DBMET03314 0.561 0.011 DBMET03315 | DBMET03315 | |
| 0.322 | 0.008 | 0.391 | Succinate dehydrogenase inhibitor | 0.252 0.022 DBMET00785 0.221 0.035 DBMET03313 0.391 0.004 DBMET00637 0.317 0.008 DBMET00703 0.249 0.022 DBMET00704 0.239 0.026 DBMET03314 0.179 0.069 DBMET03316 0.209 0.042 DBMET00784 0.239 0.026 DBMET03315 | DBMET00637 | |
| 0.349 | 0.041 | 0.384 | DNA damaging | 0.22 0.1 DBMET00785 0.384 0.032 DBMET00703 0.252 0.079 DBMET00704 0.171 0.144 DBMET03314 0.169 0.147 DBMET03316 0.171 0.144 DBMET03315 | DBMET00703 | |
| 0.358 | 0.052 | 0.615 | Apoptosis antagonist | 0.331 0.066 DBMET00785 0.249 0.129 DBMET03313 0.466 0.025 DBMET00637 0.365 0.049 DBMET00703 0.325 0.07 DBMET00704 0.296 0.088 DBMET03314 0.615 0.008 DBMET03316 0.207 0.17 DBMET00784 0.296 0.088 DBMET03315 | DBMET03316 | |
| 0.325 | 0.024 | 0.325 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | |||
| 0.304 | 0.004 | 0.304 | Alcohol oxidase inhibitor | 0.15 0.01 DBMET00785 0.183 0.007 DBMET00637 0.119 0.014 DBMET00703 0.071 0.028 DBMET00704 0.156 0.01 DBMET03314 0.156 0.01 DBMET03315 | ||
| 0.312 | 0.015 | 0.449 | Alpha-N-acetylglucosaminidase inhibitor | 0.298 0.016 DBMET00785 0.345 0.012 DBMET00637 0.22 0.029 DBMET00703 0.151 0.054 DBMET00704 0.331 0.013 DBMET03314 0.449 0.007 DBMET03316 0.331 0.013 DBMET03315 | DBMET03316 | |
| 0.297 | 0.005 | 0.448 | Porphobilinogen synthase inhibitor | 0.182 0.014 DBMET00785 0.135 0.024 DBMET03313 0.448 0.004 DBMET00637 0.099 0.036 DBMET00703 0.125 0.027 DBMET03314 0.125 0.027 DBMET03315 | DBMET00637 | |
| 0.338 | 0.048 | 0.338 | Sodium/bile acid cotransporter inhibitor | 0.297 0.082 DBMET00785 0.321 0.061 DBMET03313 0.315 0.066 DBMET00637 0.336 0.049 DBMET00703 0.302 0.077 DBMET00704 0.315 0.066 DBMET03314 0.215 0.168 DBMET03316 0.314 0.067 DBMET00784 0.315 0.066 DBMET03315 | ||
| 0.306 | 0.016 | 0.528 | Neurotrophic factor enhancer | 0.318 0.014 DBMET00785 0.442 0.005 DBMET00637 0.293 0.02 DBMET00703 0.301 0.018 DBMET00704 0.275 0.026 DBMET03314 0.528 0.004 DBMET03316 0.275 0.026 DBMET03315 | DBMET03316 | |
| 0.4 | 0.111 | 0.745 | Caspase 9 stimulant | 0.504 0.058 DBMET00785 0.745 0.018 DBMET00637 0.529 0.05 DBMET00703 0.621 0.033 DBMET00704 0.458 0.079 DBMET03314 0.743 0.019 DBMET03316 0.458 0.079 DBMET03315 | DBMET00637 | |
| 0.297 | 0.01 | 0.517 | Cystathionine beta-synthase inhibitor | 0.338 0.007 DBMET00785 0.312 0.009 DBMET00637 0.517 0.004 DBMET00703 0.305 0.009 DBMET00704 0.27 0.013 DBMET03314 0.271 0.012 DBMET03316 0.27 0.013 DBMET03315 | DBMET00703 | |
| 0.314 | 0.03 | 0.458 | Anesthetic general | 0.364 0.022 DBMET00785 0.437 0.012 DBMET00637 0.433 0.013 DBMET00703 0.353 0.023 DBMET00704 0.312 0.03 DBMET03314 0.458 0.011 DBMET03316 0.312 0.03 DBMET03315 | DBMET03316 | |
| 0.336 | 0.057 | 0.61 | Spasmolytic | 0.479 0.026 DBMET00785 0.228 0.102 DBMET03313 0.255 0.089 DBMET00637 0.439 0.033 DBMET00703 0.497 0.023 DBMET00704 0.61 0.012 DBMET03314 0.421 0.036 DBMET03316 0.206 0.114 DBMET00784 0.61 0.012 DBMET03315 | DBMET03315 | |
| 0.33 | 0.052 | 0.766 | Antioxidant | 0.387 0.037 DBMET00785 0.453 0.026 DBMET03313 0.55 0.015 DBMET00637 0.432 0.03 DBMET00703 0.389 0.037 DBMET00704 0.346 0.047 DBMET03314 0.766 0.005 DBMET03316 0.352 0.046 DBMET00784 0.346 0.047 DBMET03315 | DBMET03316 | |
| 0.331 | 0.055 | 0.438 | Interleukin 2 agonist | 0.392 0.03 DBMET00785 0.221 0.155 DBMET03313 0.264 0.104 DBMET00637 0.405 0.026 DBMET00703 0.328 0.056 DBMET00704 0.403 0.027 DBMET03314 0.438 0.018 DBMET03316 0.403 0.027 DBMET03315 | DBMET03316 | |
| 0.319 | 0.048 | 0.403 | Insulysin inhibitor | 0.401 0.022 DBMET00785 0.351 0.034 DBMET00637 0.403 0.022 DBMET00703 0.378 0.026 DBMET00704 0.305 0.056 DBMET03314 0.305 0.056 DBMET03315 | DBMET00703 | |
| 0.271 | 0.004 | 0.358 | Adrenaline agonist | 0.221 0.005 DBMET00785 0.11 0.031 DBMET03313 0.101 0.036 DBMET00637 0.111 0.03 DBMET00703 0.182 0.009 DBMET00704 0.358 0.003 DBMET03314 0.358 0.003 DBMET03315 | DBMET03315 | |
| 0.267 | 0.004 | 0.267 | HIV-1 integrase (Overall Integration) inhibitor | 0.205 0.011 DBMET00785 0.192 0.013 DBMET03313 0.242 0.005 DBMET00637 0.211 0.009 DBMET00703 0.142 0.028 DBMET00704 0.231 0.007 DBMET03314 0.105 0.05 DBMET00784 0.231 0.007 DBMET03315 | ||
| 0.268 | 0.011 | 0.268 | Ferrochelatase inhibitor | 0.172 0.03 DBMET00785 0.212 0.02 DBMET00637 0.096 0.075 DBMET00703 0.229 0.016 DBMET03314 0.229 0.016 DBMET03315 | ||
| 0.256 | 0.005 | 0.278 | Keratolytic | 0.197 0.009 DBMET00785 0.07 0.065 DBMET03313 0.191 0.009 DBMET00637 0.278 0.004 DBMET00703 0.206 0.008 DBMET00704 0.145 0.015 DBMET03314 0.145 0.015 DBMET03315 | DBMET00703 | |
| 0.323 | 0.075 | 0.742 | Antithrombotic | 0.382 0.054 DBMET00785 0.495 0.03 DBMET03313 0.318 0.077 DBMET00637 0.464 0.035 DBMET00703 0.354 0.063 DBMET00704 0.456 0.037 DBMET03314 0.742 0.006 DBMET03316 0.454 0.037 DBMET00784 0.456 0.037 DBMET03315 | DBMET03316 | |
| 0.265 | 0.024 | 0.343 | Nitric-oxide synthase stimulant | 0.316 0.008 DBMET00785 0.297 0.012 DBMET00637 0.296 0.012 DBMET00703 0.315 0.008 DBMET00704 0.343 0.005 DBMET03314 0.302 0.011 DBMET03316 0.343 0.005 DBMET03315 | DBMET03315 | |
| 0.304 | 0.064 | 0.432 | Hypoxia-inducible factor 1 alpha inhibitor | 0.182 0.176 DBMET00785 0.329 0.053 DBMET00637 0.259 0.092 DBMET00703 0.219 0.131 DBMET00704 0.432 0.023 DBMET03314 0.357 0.043 DBMET03316 0.432 0.023 DBMET03315 | DBMET03315 | |
| 0.317 | 0.08 | 0.317 | Thyroid hormone beta antagonist | 0.182 0.172 DBMET00703 | ||
| 0.255 | 0.02 | 0.312 | Neurotensin receptor agonist | 0.262 0.019 DBMET00785 0.16 0.08 DBMET03313 0.171 0.06 DBMET00637 0.312 0.013 DBMET00703 0.268 0.018 DBMET00704 0.174 0.057 DBMET03314 0.168 0.066 DBMET00784 0.174 0.057 DBMET03315 | DBMET00703 | |
| 0.232 | 0.005 | 0.232 | Sphingosine 1-phosphate receptor 5 antagonist | 0.199 0.012 DBMET00785 0.186 0.019 DBMET00637 0.174 0.029 DBMET00703 0.168 0.036 DBMET00704 0.147 0.066 DBMET03314 0.147 0.066 DBMET03315 | ||
| 0.246 | 0.019 | 0.254 | Aldehyde dehydrogenase inhibitor | 0.143 0.052 DBMET00785 0.254 0.017 DBMET00637 0.131 0.061 DBMET00703 0.102 0.095 DBMET00704 0.105 0.089 DBMET03314 0.236 0.02 DBMET03316 0.105 0.089 DBMET03315 | DBMET00637 | |
| 0.236 | 0.009 | 0.236 | Alcohol dehydrogenase inhibitor | 0.145 0.022 DBMET00785 0.088 0.068 DBMET03313 0.179 0.015 DBMET00637 0.137 0.025 DBMET00703 0.1 0.052 DBMET00704 0.102 0.05 DBMET03314 0.151 0.02 DBMET03316 0.102 0.05 DBMET03315 | ||
| 0.229 | 0.004 | 0.229 | Ornithine decarboxylase inhibitor | 0.155 0.01 DBMET00785 0.108 0.036 DBMET03313 0.132 0.018 DBMET00637 0.194 0.005 DBMET00703 0.141 0.014 DBMET00704 0.165 0.008 DBMET03314 0.1 0.045 DBMET03316 0.092 0.053 DBMET00784 0.165 0.008 DBMET03315 | ||
| 0.23 | 0.005 | 0.276 | Adenylate cyclase stimulant | 0.256 0.004 DBMET00785 0.219 0.007 DBMET03313 0.215 0.008 DBMET00637 0.236 0.005 DBMET00703 0.232 0.005 DBMET00704 0.276 0.003 DBMET03314 0.16 0.047 DBMET03316 0.18 0.026 DBMET00784 0.276 0.003 DBMET03315 | DBMET03315 | |
| 0.254 | 0.032 | 0.351 | Insulin sensitizer | 0.289 0.018 DBMET00785 0.158 0.122 DBMET03313 0.215 0.059 DBMET00637 0.351 0.009 DBMET00703 0.267 0.026 DBMET00704 0.286 0.019 DBMET03314 0.185 0.09 DBMET03316 0.286 0.019 DBMET03315 | DBMET00703 | |
| 0.255 | 0.04 | 0.307 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.262 0.037 DBMET00785 0.307 0.021 DBMET00637 0.261 0.038 DBMET00703 0.268 0.035 DBMET00704 0.298 0.024 DBMET03314 0.258 0.039 DBMET03316 0.298 0.024 DBMET03315 | DBMET00637 | |
| 0.228 | 0.019 | 0.228 | 5-Lipoxygenase inhibitor | 0.112 0.055 DBMET00785 0.198 0.025 DBMET00637 0.108 0.057 DBMET00703 0.112 0.054 DBMET00704 0.089 0.072 DBMET03314 0.089 0.072 DBMET03315 | ||
| 0.306 | 0.107 | 0.306 | Toll-Like receptor agonist | 0.214 0.185 DBMET00703 0.222 0.177 DBMET03314 0.222 0.177 DBMET03315 | ||
| 0.208 | 0.01 | 0.244 | Phosphofructokinase-1 inhibitor | 0.131 0.022 DBMET00785 0.117 0.026 DBMET03313 0.154 0.017 DBMET00637 0.147 0.019 DBMET00703 0.066 0.051 DBMET00704 0.118 0.026 DBMET03314 0.244 0.008 DBMET03316 0.062 0.055 DBMET00784 0.118 0.026 DBMET03315 | DBMET03316 | |
| 0.214 | 0.018 | 0.621 | Expectorant | 0.221 0.016 DBMET00785 0.099 0.07 DBMET03313 0.21 0.018 DBMET00637 0.406 0.005 DBMET00703 0.284 0.009 DBMET00704 0.301 0.008 DBMET03314 0.621 0.003 DBMET03316 0.109 0.059 DBMET00784 0.301 0.008 DBMET03315 | DBMET03316 | |
| 0.229 | 0.032 | 0.588 | Melanin inhibitor | 0.318 0.02 DBMET00785 0.387 0.013 DBMET00637 0.376 0.014 DBMET00703 0.36 0.015 DBMET00704 0.331 0.018 DBMET03314 0.588 0.004 DBMET03316 0.331 0.018 DBMET03315 | DBMET03316 | |
| 0.206 | 0.012 | 0.354 | Mucolytic | 0.217 0.01 DBMET00785 0.118 0.056 DBMET03313 0.212 0.011 DBMET00637 0.354 0.004 DBMET00703 0.254 0.006 DBMET00704 0.27 0.005 DBMET03314 0.255 0.006 DBMET03316 0.127 0.048 DBMET00784 0.27 0.005 DBMET03315 | DBMET00703 | |
| 0.299 | 0.11 | 0.299 | Toll-Like receptor 7 agonist | 0.208 0.191 DBMET00703 0.217 0.181 DBMET03314 0.217 0.181 DBMET03315 | ||
| 0.193 | 0.004 | 0.193 | Sphingosine 1-phosphate receptor 4 agonist | 0.102 0.024 DBMET00785 0.102 0.024 DBMET00703 0.081 0.036 DBMET03314 0.081 0.036 DBMET03315 | ||
| 0.211 | 0.024 | 0.238 | Arachidonic acid antagonist | 0.189 0.044 DBMET00785 0.149 0.09 DBMET03313 0.238 0.009 DBMET00637 0.184 0.049 DBMET00703 0.167 0.068 DBMET00704 0.172 0.063 DBMET03314 0.184 0.049 DBMET03316 0.172 0.063 DBMET03315 | DBMET00637 | |
| 0.274 | 0.087 | 0.548 | Immunostimulant | 0.37 0.059 DBMET00785 0.371 0.058 DBMET03313 0.278 0.086 DBMET00637 0.411 0.046 DBMET00703 0.32 0.073 DBMET00704 0.41 0.047 DBMET03314 0.548 0.023 DBMET03316 0.297 0.079 DBMET00784 0.41 0.047 DBMET03315 | DBMET03316 | |
| 0.29 | 0.102 | 0.335 | Calcium channel activator | 0.282 0.11 DBMET00785 0.326 0.068 DBMET00637 0.326 0.068 DBMET00703 0.331 0.064 DBMET00704 0.335 0.061 DBMET03314 0.335 0.061 DBMET03315 | DBMET03315 | |
| 0.197 | 0.013 | 0.32 | Vanilloid 1 agonist | 0.227 0.007 DBMET00785 0.168 0.024 DBMET03313 0.209 0.01 DBMET00637 0.32 0.004 DBMET00703 0.296 0.004 DBMET00704 0.164 0.027 DBMET03314 0.193 0.014 DBMET03316 0.172 0.022 DBMET00784 0.164 0.027 DBMET03315 | DBMET00703 | |
| 0.204 | 0.02 | 0.269 | Aminopeptidase B inhibitor | 0.268 0.011 DBMET00785 0.237 0.014 DBMET03313 0.183 0.026 DBMET00637 0.269 0.011 DBMET00703 0.196 0.022 DBMET00704 0.192 0.023 DBMET03314 0.186 0.025 DBMET00784 0.192 0.023 DBMET03315 | DBMET00703 | |
| 0.213 | 0.03 | 0.857 | Monophenol monooxygenase inhibitor | 0.299 0.018 DBMET00785 0.148 0.048 DBMET03313 0.541 0.006 DBMET00637 0.501 0.008 DBMET00703 0.323 0.016 DBMET00704 0.27 0.021 DBMET03314 0.857 0.002 DBMET03316 0.109 0.069 DBMET00784 0.27 0.021 DBMET03315 | DBMET03316 | |
| 0.201 | 0.018 | 0.42 | Bronchodilator | 0.153 0.03 DBMET00785 0.107 0.057 DBMET00637 0.116 0.047 DBMET00703 0.197 0.019 DBMET00704 0.42 0.005 DBMET03314 0.091 0.073 DBMET03316 0.106 0.057 DBMET00784 0.42 0.005 DBMET03315 | DBMET03315 | |
| 0.203 | 0.022 | 0.328 | Toll-Like receptor 2 antagonist | 0.24 0.011 DBMET00785 0.211 0.019 DBMET00637 0.328 0.004 DBMET00703 0.266 0.007 DBMET00704 0.205 0.022 DBMET03314 0.205 0.022 DBMET03315 | DBMET00703 | |
| 0.183 | 0.003 | 0.183 | Glutamate (mGluR6) antagonist | 0.104 0.009 DBMET00785 0.078 0.026 DBMET03313 0.075 0.031 DBMET00637 0.141 0.004 DBMET00703 0.081 0.023 DBMET00704 0.106 0.009 DBMET03314 0.071 0.037 DBMET00784 0.106 0.009 DBMET03315 | ||
| 0.218 | 0.044 | 0.379 | Thrombolytic | 0.238 0.037 DBMET00785 0.273 0.029 DBMET03313 0.138 0.092 DBMET00637 0.298 0.024 DBMET00703 0.196 0.054 DBMET00704 0.189 0.057 DBMET03314 0.379 0.013 DBMET03316 0.226 0.041 DBMET00784 0.189 0.057 DBMET03315 | DBMET03316 | |
| 0.251 | 0.078 | 0.288 | Gastrin inhibitor | 0.25 0.079 DBMET00785 0.229 0.106 DBMET00637 0.288 0.042 DBMET00703 0.212 0.131 DBMET00704 | DBMET00703 | |
| 0.183 | 0.013 | 0.183 | Sphingosine 1-phosphate receptor 4 antagonist | 0.149 0.034 DBMET00785 0.164 0.023 DBMET00637 0.127 0.06 DBMET00703 0.127 0.06 DBMET00704 | ||
| 0.187 | 0.018 | 0.254 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.254 0.009 DBMET00785 0.214 0.014 DBMET00637 0.247 0.01 DBMET00703 0.156 0.025 DBMET00704 0.195 0.017 DBMET03314 0.234 0.011 DBMET03316 0.195 0.017 DBMET03315 | DBMET00785 | |
| 0.242 | 0.074 | 0.509 | Vasodilator | 0.221 0.089 DBMET00785 0.402 0.023 DBMET00637 0.26 0.064 DBMET00703 0.236 0.078 DBMET00704 0.429 0.019 DBMET03314 0.509 0.011 DBMET03316 0.429 0.019 DBMET03315 | DBMET03316 | |
| 0.181 | 0.014 | 0.188 | Sphingosine 1-phosphate receptor 2 antagonist | 0.188 0.011 DBMET00785 0.172 0.019 DBMET00637 0.163 0.027 DBMET00703 0.168 0.022 DBMET00704 0.159 0.031 DBMET03314 0.159 0.031 DBMET03315 | DBMET00785 | |
| 0.289 | 0.123 | 0.453 | GABA C receptor rho-3 antagonist | 0.349 0.086 DBMET00785 0.453 0.04 DBMET00637 0.248 0.156 DBMET03314 0.248 0.156 DBMET03315 | DBMET00637 | |
| 0.179 | 0.013 | 0.179 | Aminoacyl-tRNA synthetase inhibitor | 0.121 0.029 DBMET00785 0.125 0.028 DBMET03313 0.178 0.013 DBMET00703 0.099 0.046 DBMET00704 0.159 0.017 DBMET03314 0.111 0.036 DBMET00784 0.159 0.017 DBMET03315 | ||
| 0.243 | 0.081 | 0.639 | Hypoglycemic | 0.329 0.043 DBMET00785 0.17 0.148 DBMET00637 0.382 0.031 DBMET00703 0.289 0.057 DBMET00704 0.339 0.04 DBMET03314 0.639 0.006 DBMET03316 0.339 0.04 DBMET03315 | DBMET03316 | |
| 0.214 | 0.057 | 0.564 | Hepatoprotectant | 0.19 0.072 DBMET00785 0.252 0.042 DBMET03313 0.28 0.035 DBMET00637 0.284 0.034 DBMET00703 0.202 0.064 DBMET00704 0.199 0.066 DBMET03314 0.564 0.005 DBMET03316 0.227 0.051 DBMET00784 0.199 0.066 DBMET03315 | DBMET03316 | |
| 0.18 | 0.027 | 0.483 | Cyclooxygenase 3 inhibitor | 0.207 0.016 DBMET00785 0.191 0.022 DBMET00637 0.263 0.008 DBMET00703 0.216 0.014 DBMET00704 0.205 0.017 DBMET03314 0.483 0.003 DBMET03316 0.205 0.017 DBMET03315 | DBMET03316 | |
| 0.231 | 0.079 | 0.759 | Angiogenesis stimulant | 0.362 0.029 DBMET00785 0.444 0.016 DBMET03313 0.174 0.108 DBMET00637 0.37 0.028 DBMET00703 0.336 0.037 DBMET00704 0.305 0.047 DBMET03314 0.759 0.004 DBMET03316 0.403 0.021 DBMET00784 0.305 0.047 DBMET03315 | DBMET03316 | |
| 0.156 | 0.004 | 0.156 | Growth hormone releasing factor agonist | 0.049 0.014 DBMET03313 0.041 0.018 DBMET00784 | ||
| 0.16 | 0.01 | 0.16 | Carbamoyl phosphate synthetase inhibitor | 0.119 0.016 DBMET00785 0.092 0.023 DBMET03313 0.099 0.021 DBMET00637 0.132 0.014 DBMET00703 0.064 0.039 DBMET00704 0.121 0.015 DBMET03314 0.059 0.044 DBMET00784 0.121 0.015 DBMET03315 | ||
| 0.194 | 0.047 | 0.529 | Diuretic | 0.151 0.077 DBMET00785 0.529 0.006 DBMET03313 0.24 0.032 DBMET00637 0.133 0.092 DBMET03314 0.451 0.01 DBMET03316 0.414 0.012 DBMET00784 0.133 0.092 DBMET03315 | DBMET03313 | |
| 0.218 | 0.075 | 0.296 | Interleukin antagonist | 0.296 0.049 DBMET00785 0.207 0.08 DBMET00637 0.262 0.057 DBMET00703 0.249 0.062 DBMET00704 0.249 0.062 DBMET03314 0.249 0.062 DBMET03315 | DBMET00785 | |
| 0.166 | 0.023 | 0.289 | Carbonic anhydrase III inhibitor | 0.289 0.006 DBMET00785 0.142 0.032 DBMET03313 0.218 0.013 DBMET00637 0.267 0.008 DBMET00703 0.27 0.007 DBMET00704 0.248 0.009 DBMET03314 0.137 0.034 DBMET03316 0.097 0.065 DBMET00784 0.248 0.009 DBMET03315 | DBMET00785 | |
| 0.149 | 0.008 | 0.19 | GABA aminotransferase inhibitor | 0.184 0.005 DBMET00785 0.125 0.014 DBMET00637 0.19 0.005 DBMET00703 0.138 0.01 DBMET00704 0.123 0.015 DBMET03314 0.103 0.025 DBMET03316 0.123 0.015 DBMET03315 | DBMET00703 | |
| 0.159 | 0.018 | 0.35 | Triose-phosphate isomerase inhibitor | 0.115 0.035 DBMET00785 0.35 0.004 DBMET03313 0.187 0.012 DBMET00637 0.096 0.052 DBMET00703 0.133 0.026 DBMET03314 0.302 0.005 DBMET03316 0.23 0.008 DBMET00784 0.133 0.026 DBMET03315 | DBMET03313 | |
| 0.155 | 0.015 | 0.208 | Inducible nitric-oxide synthase inhibitor | 0.146 0.017 DBMET00785 0.119 0.025 DBMET03313 0.114 0.027 DBMET00637 0.208 0.007 DBMET00703 0.123 0.023 DBMET00704 0.109 0.03 DBMET03314 0.108 0.031 DBMET00784 0.109 0.03 DBMET03315 | DBMET00703 | |
| 0.143 | 0.003 | 0.143 | Calcium-sensing receptor antagonist | 0.05 0.005 DBMET03313 0.044 0.005 DBMET00784 | ||
| 0.145 | 0.006 | 0.182 | Beta adrenoreceptor antagonist | 0.114 0.012 DBMET00785 0.066 0.045 DBMET03313 0.09 0.021 DBMET00637 0.09 0.021 DBMET00703 0.118 0.01 DBMET00704 0.182 0.004 DBMET03314 0.182 0.004 DBMET03315 | DBMET03315 | |
| 0.186 | 0.049 | 0.634 | Amylase inhibitor | 0.256 0.026 DBMET00785 0.258 0.026 DBMET00637 0.372 0.011 DBMET00703 0.275 0.022 DBMET00704 0.3 0.018 DBMET03314 0.634 0.004 DBMET03316 0.3 0.018 DBMET03315 | DBMET03316 | |
| 0.18 | 0.042 | 0.523 | Hemostatic | 0.203 0.031 DBMET00785 0.523 0.004 DBMET03313 0.19 0.037 DBMET00703 0.177 0.044 DBMET00704 0.142 0.078 DBMET03314 0.367 0.01 DBMET03316 0.469 0.005 DBMET00784 0.142 0.078 DBMET03315 | DBMET03313 | |
| 0.141 | 0.005 | 0.167 | GABA B receptor agonist | 0.124 0.006 DBMET00785 0.084 0.034 DBMET03313 0.127 0.006 DBMET00637 0.167 0.004 DBMET00703 0.122 0.007 DBMET00704 0.136 0.005 DBMET03314 0.074 0.055 DBMET00784 0.136 0.005 DBMET03315 | DBMET00703 | |
| 0.155 | 0.02 | 0.194 | Carbonic anhydrase VI inhibitor | 0.175 0.016 DBMET00785 0.128 0.027 DBMET03313 0.194 0.014 DBMET00637 0.193 0.014 DBMET00703 0.174 0.017 DBMET00704 0.11 0.034 DBMET03314 0.101 0.038 DBMET03316 0.091 0.046 DBMET00784 0.11 0.034 DBMET03315 | DBMET00637 | |
| 0.158 | 0.024 | 0.202 | Adenylate kinase inhibitor | 0.151 0.026 DBMET00785 0.099 0.068 DBMET03313 0.202 0.015 DBMET00637 0.144 0.029 DBMET00703 0.099 0.07 DBMET00704 0.172 0.02 DBMET03314 0.128 0.037 DBMET03316 0.172 0.02 DBMET03315 | DBMET00637 | |
| 0.214 | 0.08 | 0.283 | RNA-directed DNA polymerase inhibitor | 0.257 0.045 DBMET00785 0.283 0.035 DBMET03313 0.239 0.057 DBMET00637 0.204 0.094 DBMET00703 0.237 0.058 DBMET00704 0.233 0.062 DBMET03314 0.205 0.092 DBMET03316 0.233 0.061 DBMET00784 0.233 0.062 DBMET03315 | DBMET03313 | |
| 0.224 | 0.09 | 0.368 | DNA synthesis inhibitor | 0.254 0.064 DBMET00785 0.221 0.093 DBMET00637 0.252 0.065 DBMET00703 0.214 0.102 DBMET00704 0.268 0.057 DBMET03314 0.368 0.027 DBMET03316 0.268 0.057 DBMET03315 | DBMET03316 | |
| 0.153 | 0.021 | 0.247 | Prolactin inhibitor | 0.241 0.005 DBMET00785 0.186 0.011 DBMET00637 0.247 0.004 DBMET00703 0.189 0.011 DBMET00704 0.148 0.023 DBMET03314 0.148 0.023 DBMET03315 | DBMET00703 | |
| 0.184 | 0.053 | 0.305 | ATPase inhibitor | 0.174 0.065 DBMET00785 0.184 0.053 DBMET00637 0.154 0.094 DBMET00703 0.178 0.061 DBMET00704 0.158 0.088 DBMET03314 0.305 0.005 DBMET03316 0.158 0.088 DBMET03315 | DBMET03316 | |
| 0.134 | 0.005 | 0.157 | Beta 2 adrenoreceptor antagonist | 0.091 0.009 DBMET00785 0.058 0.026 DBMET03313 0.065 0.02 DBMET00637 0.065 0.02 DBMET00703 0.084 0.01 DBMET00704 0.157 0.004 DBMET03314 0.157 0.004 DBMET03315 | DBMET03315 | |
| 0.172 | 0.043 | 0.267 | M18 aspartyl aminopeptidase inhibitor | 0.222 0.027 DBMET00785 0.267 0.017 DBMET00637 0.162 0.047 DBMET00703 0.191 0.036 DBMET00704 0.263 0.018 DBMET03314 0.263 0.018 DBMET03315 | DBMET00637 | |
| 0.141 | 0.014 | 0.213 | Aminopeptidase I inhibitor | 0.213 0.006 DBMET00785 0.134 0.016 DBMET00637 0.167 0.01 DBMET00703 0.134 0.016 DBMET00704 0.146 0.013 DBMET03314 0.146 0.013 DBMET03315 | DBMET00785 | |
| 0.156 | 0.029 | 0.168 | Ca2+-transporting ATPase inhibitor | 0.153 0.035 DBMET00785 0.168 0.014 DBMET00637 0.14 0.072 DBMET00703 0.14 0.072 DBMET00704 0.159 0.025 DBMET03314 0.159 0.025 DBMET03316 0.159 0.025 DBMET03315 | DBMET00637 | |
| 0.172 | 0.045 | 0.345 | Cell wall synthesis inhibitor | 0.159 0.057 DBMET00785 0.345 0.008 DBMET03313 0.126 0.091 DBMET00637 0.144 0.071 DBMET00703 0.245 0.017 DBMET03314 0.272 0.012 DBMET03316 0.251 0.016 DBMET00784 0.245 0.017 DBMET03315 | DBMET03313 | |
| 0.125 | 0.002 | 0.132 | Glutamate (mGluR8) agonist | 0.076 0.004 DBMET00785 0.05 0.011 DBMET03313 0.048 0.013 DBMET00637 0.132 0.002 DBMET00703 0.06 0.007 DBMET00704 0.064 0.006 DBMET03314 0.042 0.019 DBMET00784 0.064 0.006 DBMET03315 | DBMET00703 | |
| 0.14 | 0.018 | 0.215 | Glutamate dehydrogenase inhibitor | 0.161 0.014 DBMET00785 0.076 0.049 DBMET03313 0.159 0.014 DBMET00637 0.215 0.009 DBMET00703 0.085 0.04 DBMET00704 0.157 0.015 DBMET03314 0.092 0.036 DBMET03316 0.157 0.015 DBMET03315 | DBMET00703 | |
| 0.146 | 0.024 | 0.188 | Nitric-oxide synthase inhibitor | 0.188 0.012 DBMET00785 0.095 0.069 DBMET03313 0.109 0.048 DBMET00637 0.176 0.015 DBMET00703 0.152 0.022 DBMET00704 0.109 0.047 DBMET03314 0.109 0.047 DBMET03315 | DBMET00785 | |
| 0.176 | 0.054 | 0.219 | Acetylcholine M1 receptor antagonist | 0.185 0.049 DBMET00785 0.138 0.087 DBMET00637 0.134 0.091 DBMET00703 0.143 0.081 DBMET00704 0.219 0.035 DBMET03314 0.219 0.035 DBMET03315 | DBMET03315 | |
| 0.128 | 0.008 | 0.178 | Beta 3 adrenoreceptor antagonist | 0.121 0.009 DBMET00785 0.067 0.038 DBMET03313 0.084 0.02 DBMET00637 0.077 0.025 DBMET00703 0.117 0.01 DBMET00704 0.178 0.004 DBMET03314 0.178 0.004 DBMET03315 | DBMET03315 | |
| 0.125 | 0.005 | 0.125 | Sphingosine 1-phosphate receptor 5 agonist | 0.054 0.036 DBMET03313 0.053 0.038 DBMET00784 | ||
| 0.122 | 0.004 | 0.127 | Glutamate (mGluR group III) antagonist | 0.054 0.017 DBMET00785 0.127 0.004 DBMET00703 | DBMET00703 | |
| 0.145 | 0.029 | 0.145 | Potassium channel (Ca-activated) activator | 0.078 0.077 DBMET00785 | ||
| 0.158 | 0.045 | 0.21 | DNA polymerase I inhibitor | 0.167 0.041 DBMET00785 0.095 0.091 DBMET03313 0.205 0.026 DBMET00637 0.168 0.04 DBMET00703 0.149 0.05 DBMET00704 0.147 0.051 DBMET03314 0.21 0.025 DBMET03316 0.147 0.051 DBMET03315 | DBMET03316 | |
| 0.156 | 0.044 | 0.197 | Interleukin 4 antagonist | 0.154 0.046 DBMET00785 0.166 0.038 DBMET00637 0.148 0.052 DBMET00703 0.153 0.047 DBMET00704 0.197 0.023 DBMET03314 0.165 0.038 DBMET03316 0.197 0.023 DBMET03315 | DBMET03315 | |
| 0.17 | 0.057 | 0.4 | Interferon gamma antagonist | 0.239 0.03 DBMET00785 0.207 0.038 DBMET00637 0.263 0.026 DBMET00703 0.223 0.034 DBMET00704 0.206 0.039 DBMET03314 0.4 0.011 DBMET03316 0.206 0.039 DBMET03315 | DBMET03316 | |
| 0.137 | 0.026 | 0.159 | Anabolic | 0.141 0.023 DBMET00785 0.154 0.016 DBMET03313 0.159 0.013 DBMET00637 0.106 0.055 DBMET00703 0.108 0.052 DBMET00704 0.152 0.017 DBMET03314 0.099 0.064 DBMET03316 0.127 0.033 DBMET00784 0.152 0.017 DBMET03315 | DBMET00637 | |
| 0.125 | 0.014 | 0.197 | Argininosuccinate synthase inhibitor | 0.162 0.01 DBMET00785 0.148 0.012 DBMET00637 0.197 0.008 DBMET00703 0.071 0.029 DBMET00704 0.141 0.012 DBMET03314 0.07 0.03 DBMET03316 0.141 0.012 DBMET03315 | DBMET00703 | |
| 0.12 | 0.01 | 0.152 | Estrogen-related receptor beta agonist | 0.123 0.009 DBMET00785 0.152 0.004 DBMET00637 0.112 0.014 DBMET00703 0.117 0.011 DBMET00704 0.095 0.032 DBMET03314 0.095 0.032 DBMET03315 | DBMET00637 | |
| 0.121 | 0.013 | 0.121 | D-Ala-D-Ala ligase inhibitor | 0.101 0.028 DBMET00785 0.11 0.019 DBMET00637 0.093 0.039 DBMET00703 0.09 0.045 DBMET00704 0.097 0.033 DBMET03314 0.097 0.033 DBMET03315 | ||
| 0.165 | 0.058 | 0.431 | Lipid peroxidase inhibitor | 0.232 0.031 DBMET00785 0.162 0.06 DBMET03313 0.308 0.018 DBMET00637 0.27 0.023 DBMET00703 0.221 0.034 DBMET00704 0.183 0.049 DBMET03314 0.431 0.008 DBMET03316 0.183 0.049 DBMET03315 | DBMET03316 | |
| 0.11 | 0.005 | 0.11 | GHS receptor agonist | 0.041 0.032 DBMET00785 0.045 0.025 DBMET03313 0.046 0.024 DBMET00784 | ||
| 0.128 | 0.023 | 0.149 | Glutamate (mGluR7) agonist | 0.104 0.053 DBMET00785 0.149 0.012 DBMET00703 0.117 0.033 DBMET00704 0.118 0.032 DBMET03314 0.118 0.032 DBMET03315 | DBMET00703 | |
| 0.108 | 0.004 | 0.108 | Growth hormone release promoting | 0.027 0.011 DBMET03313 0.019 0.014 DBMET00784 | ||
| 0.118 | 0.014 | 0.118 | Biliverdin reductase inhibitor | 0.074 0.029 DBMET00785 0.091 0.021 DBMET00637 0.054 0.048 DBMET00703 0.068 0.033 DBMET03314 0.068 0.033 DBMET03315 | ||
| 0.108 | 0.006 | 0.108 | Growth hormone secretagogue receptor antagonist | |||
| 0.138 | 0.036 | 0.252 | Carbonic anhydrase XV inhibitor | 0.252 0.012 DBMET00785 0.095 0.075 DBMET03313 0.232 0.014 DBMET00637 0.181 0.022 DBMET00703 0.243 0.013 DBMET00704 0.199 0.019 DBMET03314 0.199 0.019 DBMET03315 | DBMET00785 | |
| 0.161 | 0.061 | 0.384 | Protein kinase stimulant | 0.19 0.045 DBMET00785 0.198 0.042 DBMET00637 0.233 0.031 DBMET00703 0.2 0.041 DBMET00704 0.221 0.035 DBMET03314 0.384 0.009 DBMET03316 0.221 0.035 DBMET03315 | DBMET03316 | |
| 0.104 | 0.004 | 0.173 | Dopamine D5 agonist | 0.173 0.002 DBMET00785 0.15 0.003 DBMET00637 0.08 0.006 DBMET00703 0.111 0.004 DBMET00704 0.085 0.005 DBMET03314 0.085 0.005 DBMET03315 | DBMET00785 | |
| 0.137 | 0.038 | 0.154 | GABA C receptor antagonist | 0.154 0.028 DBMET00785 0.14 0.036 DBMET00637 0.103 0.073 DBMET00703 0.103 0.073 DBMET00704 0.118 0.054 DBMET03314 0.118 0.054 DBMET03315 | DBMET00785 | |
| 0.114 | 0.015 | 0.114 | Sphingosine 1-phosphate receptor antagonist | 0.082 0.041 DBMET00637 0.091 0.029 DBMET03314 0.091 0.029 DBMET03315 | ||
| 0.171 | 0.072 | 0.171 | Antipruritic | 0.141 0.106 DBMET00785 | ||
| 0.098 | 0.004 | 0.131 | Beta 2 adrenoreceptor agonist | 0.104 0.004 DBMET00785 0.071 0.017 DBMET03313 0.071 0.017 DBMET00637 0.069 0.021 DBMET00703 0.088 0.006 DBMET00704 0.131 0.003 DBMET03314 0.131 0.003 DBMET03315 | DBMET03315 | |
| 0.102 | 0.01 | 0.152 | Beta 1 adrenoreceptor antagonist | 0.095 0.011 DBMET00785 0.081 0.017 DBMET00637 0.071 0.025 DBMET00703 0.096 0.011 DBMET00704 0.152 0.005 DBMET03314 0.152 0.005 DBMET03315 | DBMET03315 | |
| 0.097 | 0.004 | 0.097 | Arginase inhibitor | 0.066 0.009 DBMET00785 0.031 0.03 DBMET03313 0.074 0.007 DBMET00703 0.036 0.025 DBMET00704 0.047 0.017 DBMET03314 0.058 0.011 DBMET03316 0.047 0.017 DBMET03315 | ||
| 0.121 | 0.029 | 0.401 | Carbonic anhydrase XIII inhibitor | 0.116 0.031 DBMET00785 0.401 0.004 DBMET03313 0.167 0.019 DBMET00637 0.157 0.02 DBMET00703 0.142 0.023 DBMET00704 0.086 0.046 DBMET03314 0.248 0.009 DBMET03316 0.375 0.004 DBMET00784 0.086 0.046 DBMET03315 | DBMET03313 | |
| 0.097 | 0.007 | 0.097 | Sphingosine 1-phosphate receptor 3 agonist | 0.042 0.02 DBMET03313 0.033 0.025 DBMET00784 | ||
| 0.121 | 0.033 | 0.313 | Catalase inhibitor | 0.206 0.014 DBMET00785 0.164 0.023 DBMET03313 0.216 0.012 DBMET00637 0.313 0.005 DBMET00703 0.185 0.018 DBMET00704 0.214 0.013 DBMET03314 0.179 0.019 DBMET00784 0.214 0.013 DBMET03315 | DBMET00703 | |
| 0.118 | 0.03 | 0.215 | NADH dehydrogenase inhibitor | 0.129 0.024 DBMET00785 0.13 0.024 DBMET00637 0.101 0.042 DBMET00703 0.095 0.05 DBMET00704 0.139 0.02 DBMET03314 0.215 0.009 DBMET03316 0.139 0.02 DBMET03315 | DBMET03316 | |
| 0.188 | 0.103 | 0.343 | Hypolipemic | 0.201 0.093 DBMET00637 0.343 0.037 DBMET03316 | DBMET03316 | |
| 0.154 | 0.07 | 0.251 | Phospholipase A2 inhibitor | 0.193 0.047 DBMET00785 0.123 0.113 DBMET03313 0.251 0.023 DBMET00637 0.24 0.026 DBMET00703 0.16 0.065 DBMET00704 0.172 0.058 DBMET03314 0.208 0.038 DBMET03316 0.172 0.058 DBMET03315 | DBMET00637 | |
| 0.137 | 0.052 | 0.215 | Cholesterol synthesis inhibitor | 0.132 0.055 DBMET00785 0.184 0.031 DBMET03313 0.215 0.023 DBMET00637 0.159 0.04 DBMET00703 0.141 0.05 DBMET00704 0.151 0.044 DBMET03314 0.148 0.045 DBMET03316 0.171 0.035 DBMET00784 0.151 0.044 DBMET03315 | DBMET00637 | |
| 0.144 | 0.061 | 0.198 | Heat shock protein 70 antagonist | 0.183 0.011 DBMET00785 0.155 0.036 DBMET00637 0.198 0.007 DBMET00703 0.182 0.011 DBMET00704 0.152 0.041 DBMET03314 0.161 0.026 DBMET03316 0.152 0.041 DBMET03315 | DBMET00703 | |
| 0.109 | 0.025 | 0.176 | Granulocyte macrophage colony stimulating factor agonist | 0.147 0.005 DBMET00785 0.127 0.012 DBMET00637 0.15 0.005 DBMET00703 0.176 0.004 DBMET00704 0.124 0.013 DBMET03314 0.124 0.013 DBMET03315 | DBMET00704 | |
| 0.116 | 0.034 | 0.116 | ABCA1 expression enhancer | |||
| 0.096 | 0.016 | 0.16 | Alpha 2 adrenoreceptor agonist | 0.058 0.045 DBMET00785 0.16 0.005 DBMET03314 0.16 0.005 DBMET03315 | DBMET03315 | |
| 0.09 | 0.011 | 0.171 | Glutamate (mGluR group III) agonist | 0.046 0.027 DBMET00785 0.171 0.004 DBMET00703 0.048 0.025 DBMET03314 0.048 0.025 DBMET03315 | DBMET00703 | |
| 0.09 | 0.011 | 0.09 | Sphingosine 1-phosphate receptor 1 antagonist | 0.053 0.045 DBMET00637 0.074 0.016 DBMET03314 0.074 0.016 DBMET03315 | ||
| 0.095 | 0.017 | 0.102 | Ornithine carbamoyltransferase inhibitor | 0.095 0.017 DBMET00785 0.048 0.042 DBMET03313 0.102 0.016 DBMET00703 0.048 0.041 DBMET00704 0.089 0.019 DBMET03314 0.089 0.019 DBMET03315 | DBMET00703 | |
| 0.105 | 0.028 | 0.165 | Vanilloid agonist | 0.152 0.01 DBMET00785 0.096 0.038 DBMET03313 0.16 0.009 DBMET00637 0.149 0.011 DBMET00703 0.165 0.009 DBMET00704 0.111 0.023 DBMET03314 0.094 0.041 DBMET03316 0.086 0.056 DBMET00784 0.111 0.023 DBMET03315 | DBMET00704 | |
| 0.086 | 0.011 | 0.525 | Cholecystokinin A antagonist | 0.525 0.003 DBMET03313 0.45 0.003 DBMET00784 | DBMET03313 | |
| 0.077 | 0.002 | 0.077 | Glutamate (mGluR6) agonist | 0.025 0.004 DBMET00785 0.024 0.004 DBMET03313 0.012 0.009 DBMET00637 0.072 0.002 DBMET00703 0.015 0.006 DBMET00704 0.02 0.004 DBMET03314 0.013 0.008 DBMET00784 0.02 0.004 DBMET03315 | ||
| 0.077 | 0.003 | 0.104 | Glutamate (mGluR3) agonist | 0.059 0.004 DBMET00785 0.033 0.021 DBMET03313 0.036 0.014 DBMET00637 0.104 0.002 DBMET00703 0.051 0.005 DBMET00704 0.045 0.006 DBMET03314 0.03 0.029 DBMET00784 0.045 0.006 DBMET03315 | DBMET00703 | |
| 0.132 | 0.058 | 0.296 | Adenylate cyclase inhibitor | 0.238 0.02 DBMET00785 0.151 0.044 DBMET00637 0.169 0.034 DBMET00703 0.152 0.044 DBMET00704 0.296 0.014 DBMET03314 0.296 0.014 DBMET03315 | DBMET03315 | |
| 0.086 | 0.013 | 0.086 | Sphingosine 1-phosphate receptor 3 antagonist | 0.078 0.018 DBMET00785 0.075 0.021 DBMET00637 0.055 0.046 DBMET00703 0.053 0.049 DBMET00704 0.066 0.031 DBMET03314 0.066 0.031 DBMET03315 | ||
| 0.118 | 0.045 | 0.465 | UDP-glucose 4-epimerase inhibitor | 0.132 0.036 DBMET00785 0.345 0.008 DBMET00637 0.126 0.039 DBMET03314 0.465 0.004 DBMET03316 0.126 0.039 DBMET03315 | DBMET03316 | |
| 0.084 | 0.012 | 0.086 | Aconitate hydratase inhibitor | 0.054 0.032 DBMET00785 0.086 0.012 DBMET00637 0.057 0.029 DBMET00703 0.053 0.034 DBMET03314 0.053 0.034 DBMET03315 | DBMET00637 | |
| 0.096 | 0.024 | 0.096 | Glucagon-like peptide 1 agonist | 0.084 0.032 DBMET00785 0.088 0.029 DBMET00703 0.066 0.044 DBMET00704 | ||
| 0.115 | 0.044 | 0.125 | GABA C receptor rho-1 antagonist | 0.125 0.036 DBMET00785 0.117 0.043 DBMET00637 0.104 0.057 DBMET00703 0.097 0.066 DBMET00704 0.095 0.069 DBMET03314 0.095 0.069 DBMET03315 | DBMET00785 | |
| 0.147 | 0.076 | 0.343 | NOS3 expression enhancer | 0.12 0.115 DBMET00785 0.154 0.068 DBMET00637 0.343 0.012 DBMET03316 | DBMET03316 | |
| 0.106 | 0.038 | 0.134 | Bile acid receptor antagonist | 0.117 0.022 DBMET00785 0.11 0.031 DBMET03313 0.129 0.013 DBMET00637 0.134 0.011 DBMET00703 0.108 0.034 DBMET00704 0.104 0.041 DBMET03314 0.097 0.056 DBMET03316 0.095 0.06 DBMET00784 0.104 0.041 DBMET03315 | DBMET00703 | |
| 0.093 | 0.025 | 0.138 | Glycine receptor agonist | 0.114 0.014 DBMET00785 0.09 0.028 DBMET00637 0.138 0.009 DBMET00703 0.099 0.022 DBMET00704 0.103 0.019 DBMET03314 0.075 0.046 DBMET03316 0.103 0.019 DBMET03315 | DBMET00703 | |
| 0.072 | 0.005 | 0.162 | Beta adrenoreceptor agonist | 0.074 0.005 DBMET00785 0.045 0.031 DBMET03313 0.049 0.019 DBMET00637 0.047 0.025 DBMET00703 0.059 0.009 DBMET00704 0.162 0.003 DBMET03314 0.162 0.003 DBMET03315 | DBMET03315 | |
| 0.12 | 0.053 | 0.237 | Chelator | 0.175 0.029 DBMET00785 0.222 0.021 DBMET00637 0.237 0.018 DBMET00703 0.136 0.042 DBMET00704 0.118 0.056 DBMET03314 0.109 0.066 DBMET03316 0.118 0.056 DBMET03315 | DBMET00703 | |
| 0.072 | 0.006 | 0.284 | Glutamate (mGluR3) antagonist | 0.083 0.005 DBMET00785 0.035 0.029 DBMET00637 0.284 0.003 DBMET00703 0.056 0.01 DBMET00704 0.04 0.02 DBMET03314 0.04 0.02 DBMET03315 | DBMET00703 | |
| 0.08 | 0.015 | 0.152 | Sphingosine kinase 2 inhibitor | 0.152 0.004 DBMET00785 0.095 0.009 DBMET00637 0.063 0.028 DBMET00703 0.106 0.006 DBMET00704 0.114 0.005 DBMET03314 0.114 0.005 DBMET03315 | DBMET00785 | |
| 0.121 | 0.056 | 0.209 | Photosensitizer | 0.146 0.034 DBMET00785 0.154 0.029 DBMET00637 0.176 0.019 DBMET00703 0.14 0.038 DBMET00704 0.127 0.049 DBMET03314 0.209 0.011 DBMET03316 0.127 0.049 DBMET03315 | DBMET03316 | |
| 0.081 | 0.016 | 0.149 | Sphingosine kinase inhibitor | 0.149 0.004 DBMET00785 0.095 0.009 DBMET03313 0.089 0.011 DBMET00637 0.069 0.026 DBMET00703 0.099 0.008 DBMET00704 0.099 0.008 DBMET03314 0.06 0.038 DBMET00784 0.099 0.008 DBMET03315 | DBMET00785 | |
| 0.072 | 0.008 | 0.072 | Sphingosine 1-phosphate receptor 1 agonist | 0.041 0.03 DBMET00785 0.038 0.035 DBMET03314 0.038 0.035 DBMET03315 | ||
| 0.139 | 0.075 | 0.182 | Mannose-6-phosphate isomerase inhibitor | 0.148 0.066 DBMET00785 0.182 0.041 DBMET00637 0.172 0.047 DBMET00703 0.136 0.078 DBMET00704 0.134 0.08 DBMET03314 0.177 0.045 DBMET03316 0.134 0.08 DBMET03315 | DBMET00637 | |
| 0.144 | 0.08 | 0.263 | Insulin secretagoues | 0.16 0.064 DBMET00785 0.21 0.031 DBMET00703 0.133 0.093 DBMET00704 0.128 0.1 DBMET03314 0.263 0.017 DBMET03316 0.128 0.1 DBMET03315 | DBMET03316 | |
| 0.092 | 0.029 | 0.306 | HIV-1 integrase (3'-Processing) inhibitor | 0.085 0.031 DBMET00785 0.306 0.005 DBMET03313 0.242 0.007 DBMET00637 0.106 0.024 DBMET00703 0.072 0.038 DBMET00704 0.062 0.045 DBMET03314 0.121 0.019 DBMET03316 0.189 0.01 DBMET00784 0.062 0.045 DBMET03315 | DBMET03313 | |
| 0.157 | 0.095 | 0.449 | Lipocortins synthesis antagonist | 0.449 0.005 DBMET00637 0.333 0.016 DBMET03316 | DBMET00637 | |
| 0.072 | 0.011 | 0.072 | Sphingosine 1-phosphate receptor agonist | |||
| 0.084 | 0.023 | 0.14 | Glutamate (mGluR7) antagonist | 0.09 0.017 DBMET00785 0.075 0.034 DBMET00637 0.14 0.003 DBMET00703 0.091 0.016 DBMET00704 0.076 0.033 DBMET03314 0.076 0.033 DBMET03315 | DBMET00703 | |
| 0.119 | 0.059 | 0.241 | TRPA1 agonist | 0.141 0.038 DBMET00785 0.107 0.077 DBMET03313 0.241 0.006 DBMET00637 0.116 0.064 DBMET00703 0.118 0.061 DBMET00704 0.106 0.078 DBMET03314 0.166 0.021 DBMET03316 0.106 0.078 DBMET03315 | DBMET00637 | |
| 0.071 | 0.014 | 0.448 | Cholecystokinin antagonist | 0.448 0.003 DBMET03313 0.389 0.004 DBMET00784 | DBMET03313 | |
| 0.063 | 0.006 | 0.151 | Kainate receptor agonist | 0.088 0.003 DBMET00785 0.049 0.015 DBMET00637 0.151 0.002 DBMET00703 0.069 0.005 DBMET00704 0.063 0.006 DBMET03314 0.063 0.006 DBMET03315 | DBMET00703 | |
| 0.119 | 0.063 | 0.191 | Interleukin 8 antagonist | 0.191 0.015 DBMET00785 0.147 0.036 DBMET00637 0.174 0.021 DBMET00703 0.157 0.03 DBMET00704 | DBMET00785 | |
| 0.08 | 0.025 | 0.117 | Purinergic P2X1 antagonist | 0.103 0.015 DBMET00785 0.117 0.012 DBMET00637 0.062 0.04 DBMET00703 0.066 0.036 DBMET00704 0.096 0.018 DBMET03314 0.056 0.049 DBMET03316 0.096 0.018 DBMET03315 | DBMET00637 | |
| 0.062 | 0.007 | 0.062 | Bombesin 1 receptor antagonist | 0.037 0.025 DBMET03313 0.035 0.028 DBMET00784 | ||
| 0.121 | 0.066 | 0.293 | Anesthetic local | 0.185 0.036 DBMET00785 0.129 0.06 DBMET00637 0.092 0.091 DBMET00703 0.175 0.039 DBMET00704 0.293 0.013 DBMET03314 0.293 0.013 DBMET03315 | DBMET03315 | |
| 0.12 | 0.067 | 0.146 | Acetylcholine muscarinic antagonist | 0.126 0.061 DBMET00785 0.1 0.091 DBMET00704 0.146 0.046 DBMET03314 0.146 0.046 DBMET03315 | DBMET03315 | |
| 0.24 | 0.186 | 0.695 | Antibacterial | 0.305 0.131 DBMET00785 0.426 0.066 DBMET03313 0.375 0.088 DBMET00637 0.303 0.133 DBMET00703 0.252 0.175 DBMET00704 0.461 0.053 DBMET03314 0.695 0.009 DBMET03316 0.318 0.122 DBMET00784 0.461 0.053 DBMET03315 | DBMET03316 | |
| 0.078 | 0.027 | 0.17 | Carbonic anhydrase stimulant | 0.12 0.014 DBMET00785 0.053 0.049 DBMET00637 0.17 0.009 DBMET00703 0.092 0.021 DBMET00704 0.135 0.012 DBMET03314 0.135 0.012 DBMET03315 | DBMET00703 | |
| 0.069 | 0.017 | 0.095 | Alpha-mannosidase inhibitor | 0.063 0.023 DBMET00785 0.084 0.01 DBMET03313 0.054 0.036 DBMET00637 0.067 0.019 DBMET00703 0.052 0.039 DBMET00704 0.083 0.01 DBMET03314 0.095 0.007 DBMET03316 0.076 0.013 DBMET00784 0.083 0.01 DBMET03315 | DBMET03316 | |
| 0.086 | 0.034 | 0.222 | Alpha adrenoreceptor agonist | 0.093 0.031 DBMET00785 0.091 0.032 DBMET00704 0.222 0.007 DBMET03314 0.222 0.007 DBMET03315 | DBMET03315 | |
| 0.172 | 0.121 | 0.515 | Antiamyloidogenic | 0.433 0.024 DBMET00785 0.166 0.127 DBMET00637 0.499 0.016 DBMET00703 0.515 0.015 DBMET00704 0.252 0.07 DBMET03314 0.29 0.055 DBMET03316 0.252 0.07 DBMET03315 | DBMET00704 | |
| 0.079 | 0.029 | 0.156 | NMDA receptor agonist | 0.092 0.022 DBMET00785 0.099 0.02 DBMET03313 0.156 0.007 DBMET00703 0.087 0.025 DBMET03314 0.066 0.039 DBMET00784 0.087 0.025 DBMET03315 | DBMET00703 | |
| 0.058 | 0.008 | 0.073 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.073 0.004 DBMET00785 0.067 0.005 DBMET00637 0.058 0.008 DBMET00703 0.057 0.009 DBMET00704 0.064 0.006 DBMET03314 0.064 0.006 DBMET03315 | DBMET00785 | |
| 0.083 | 0.033 | 0.092 | Secretase beta inhibitor | 0.092 0.023 DBMET00785 0.079 0.037 DBMET00704 0.073 0.045 DBMET03314 0.073 0.045 DBMET03315 | DBMET00785 | |
| 0.074 | 0.025 | 0.087 | Acyl-CoA dehydrogenase inhibitor | 0.056 0.036 DBMET00785 0.087 0.02 DBMET00637 0.055 0.037 DBMET03314 0.055 0.037 DBMET03315 | DBMET00637 | |
| 0.059 | 0.01 | 0.077 | Fumarate hydratase inhibitor | 0.052 0.013 DBMET00785 0.077 0.007 DBMET00637 0.07 0.008 DBMET00703 0.032 0.026 DBMET00704 0.044 0.016 DBMET03314 0.04 0.018 DBMET03316 0.044 0.016 DBMET03315 | DBMET00637 | |
| 0.092 | 0.045 | 0.156 | Glutathione S-transferase inhibitor | 0.132 0.017 DBMET00785 0.12 0.023 DBMET00637 0.156 0.011 DBMET00703 0.109 0.03 DBMET00704 0.12 0.023 DBMET03314 0.12 0.023 DBMET03315 | DBMET00703 | |
| 0.054 | 0.007 | 0.073 | Glutamate (mGluR8) antagonist | 0.045 0.012 DBMET00785 0.036 0.025 DBMET03313 0.073 0.004 DBMET00703 0.036 0.023 DBMET00704 0.04 0.017 DBMET03314 0.033 0.032 DBMET00784 0.04 0.017 DBMET03315 | DBMET00703 | |
| 0.053 | 0.007 | 0.053 | GHS receptor antagonist | |||
| 0.063 | 0.019 | 0.096 | Vanilloid 2 antagonist | 0.09 0.007 DBMET00785 0.059 0.025 DBMET03313 0.086 0.007 DBMET00637 0.079 0.009 DBMET00703 0.096 0.005 DBMET00704 0.07 0.014 DBMET03314 0.053 0.034 DBMET00784 0.07 0.014 DBMET03315 | DBMET00704 | |
| 0.055 | 0.011 | 0.068 | Prostacyclin antagonist | 0.068 0.008 DBMET00703 | DBMET00703 | |
| 0.07 | 0.027 | 0.132 | Carbonic anhydrase VB inhibitor | 0.078 0.023 DBMET00785 0.132 0.011 DBMET03313 0.102 0.015 DBMET00637 0.053 0.042 DBMET00703 0.053 0.042 DBMET00704 0.072 0.027 DBMET00784 | DBMET03313 | |
| 0.144 | 0.101 | 0.56 | Nitric oxide antagonist | 0.173 0.08 DBMET00785 0.128 0.122 DBMET03313 0.345 0.032 DBMET00637 0.202 0.066 DBMET00703 0.193 0.07 DBMET00704 0.18 0.076 DBMET03314 0.56 0.012 DBMET03316 0.18 0.076 DBMET03315 | DBMET03316 | |
| 0.06 | 0.017 | 0.094 | Mannosidase inhibitor | 0.053 0.023 DBMET00785 0.076 0.01 DBMET03313 0.042 0.037 DBMET00637 0.054 0.021 DBMET00703 0.076 0.01 DBMET03314 0.094 0.006 DBMET03316 0.065 0.014 DBMET00784 0.076 0.01 DBMET03315 | DBMET03316 | |
| 0.075 | 0.033 | 0.311 | HIV-1 integrase (Strand Transfer) inhibitor | 0.057 0.044 DBMET00785 0.311 0.005 DBMET03313 0.245 0.007 DBMET00637 0.082 0.03 DBMET00703 0.051 0.049 DBMET00704 0.114 0.018 DBMET03316 0.214 0.009 DBMET00784 | DBMET03313 | |
| 0.094 | 0.054 | 0.109 | Glutamate release inhibitor | 0.1 0.042 DBMET00785 0.098 0.045 DBMET00637 0.087 0.07 DBMET00703 0.094 0.053 DBMET00704 0.109 0.031 DBMET03314 0.098 0.045 DBMET03316 0.109 0.031 DBMET03315 | DBMET03315 | |
| 0.078 | 0.038 | 0.197 | Carbonic anhydrase VA inhibitor | 0.076 0.04 DBMET00785 0.197 0.005 DBMET03313 0.103 0.024 DBMET00637 0.084 0.034 DBMET00703 0.068 0.048 DBMET00704 0.17 0.007 DBMET00784 | DBMET03313 | |
| 0.063 | 0.024 | 0.066 | DNA helicase inhibitor | 0.066 0.02 DBMET00703 | DBMET00703 | |
| 0.069 | 0.031 | 0.084 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.06 0.04 DBMET00785 0.084 0.023 DBMET00637 0.056 0.045 DBMET00703 0.073 0.029 DBMET03316 | DBMET00637 | |
| 0.134 | 0.096 | 0.331 | Protein-tyrosine phosphatase inhibitor | 0.164 0.067 DBMET00785 0.331 0.014 DBMET03313 0.186 0.053 DBMET00637 0.227 0.038 DBMET00703 0.14 0.089 DBMET00704 0.179 0.056 DBMET03316 0.276 0.024 DBMET00784 | DBMET03313 | |
| 0.048 | 0.01 | 0.456 | Cholecystokinin B antagonist | 0.456 0.003 DBMET03313 0.385 0.003 DBMET00784 | DBMET03313 | |
| 0.126 | 0.09 | 0.199 | Farnesoid X receptor antagonist | 0.139 0.067 DBMET00785 0.178 0.03 DBMET00637 0.199 0.022 DBMET00703 0.127 0.088 DBMET00704 0.128 0.086 DBMET03314 0.128 0.086 DBMET03315 | DBMET00703 | |
| 0.076 | 0.041 | 0.197 | HIV-1 integrase inhibitor | 0.065 0.056 DBMET00785 0.129 0.012 DBMET03313 0.197 0.005 DBMET00637 0.084 0.035 DBMET00703 0.067 0.052 DBMET03314 0.104 0.023 DBMET03316 0.083 0.036 DBMET00784 0.067 0.052 DBMET03315 | DBMET00637 | |
| 0.06 | 0.024 | 0.074 | Bombesin 2 receptor antagonist | 0.074 0.018 DBMET00785 0.07 0.02 DBMET00703 0.068 0.02 DBMET00704 0.045 0.042 DBMET03314 0.045 0.042 DBMET03315 | DBMET00785 | |
| 0.074 | 0.039 | 0.272 | Carbonic anhydrase V inhibitor | 0.074 0.039 DBMET00785 0.272 0.004 DBMET03313 0.112 0.023 DBMET00637 0.083 0.034 DBMET00703 0.065 0.047 DBMET00704 0.23 0.005 DBMET00784 | DBMET03313 | |
| 0.04 | 0.006 | 0.077 | Thyroid hormone agonist | 0.055 0.004 DBMET00785 0.055 0.004 DBMET03313 0.052 0.004 DBMET00637 0.077 0.003 DBMET00703 0.035 0.009 DBMET00704 0.035 0.009 DBMET03314 0.029 0.014 DBMET00784 0.035 0.009 DBMET03315 | DBMET00703 | |
| 0.061 | 0.027 | 0.093 | Adenine nucleotide translocase inhibitor | 0.064 0.022 DBMET00785 0.093 0.005 DBMET03313 0.059 0.029 DBMET00637 0.069 0.016 DBMET00703 0.057 0.034 DBMET00704 0.064 0.022 DBMET03314 0.077 0.01 DBMET03316 0.077 0.01 DBMET00784 0.064 0.022 DBMET03315 | DBMET03313 | |
| 0.109 | 0.075 | 0.2 | Microtubule formation inhibitor | 0.147 0.039 DBMET00785 0.166 0.03 DBMET00637 0.155 0.035 DBMET00703 0.162 0.032 DBMET00704 0.153 0.036 DBMET03314 0.2 0.02 DBMET03316 0.153 0.036 DBMET03315 | DBMET03316 | |
| 0.109 | 0.076 | 0.183 | Proteasome inhibitor | 0.183 0.031 DBMET00785 0.166 0.038 DBMET00637 0.138 0.053 DBMET00703 0.169 0.036 DBMET00704 0.147 0.048 DBMET03314 0.147 0.048 DBMET03315 | DBMET00785 | |
| 0.048 | 0.015 | 0.048 | Glucagon-like peptide 1 receptor antagonist | |||
| 0.055 | 0.022 | 0.067 | Dopamine beta hydroxylase inhibitor | 0.067 0.01 DBMET00785 0.066 0.01 DBMET00637 0.049 0.033 DBMET00703 0.053 0.025 DBMET00704 0.049 0.033 DBMET03314 0.049 0.033 DBMET03315 | DBMET00785 | |
| 0.1 | 0.069 | 0.122 | Factor V inhibitor | 0.122 0.037 DBMET00785 0.109 0.052 DBMET00703 0.112 0.048 DBMET00704 0.105 0.059 DBMET03314 0.105 0.059 DBMET03315 | DBMET00785 | |
| 0.136 | 0.105 | 0.165 | CF transmembrane conductance regulator agonist | 0.161 0.059 DBMET00785 0.165 0.053 DBMET00637 0.13 0.118 DBMET00703 0.156 0.065 DBMET00704 | DBMET00637 | |
| 0.036 | 0.005 | 0.091 | Beta 1 adrenoreceptor agonist | 0.034 0.006 DBMET00785 0.021 0.018 DBMET00637 0.024 0.013 DBMET00703 0.028 0.01 DBMET00704 0.091 0.003 DBMET03314 0.091 0.003 DBMET03315 | DBMET03315 | |
| 0.142 | 0.113 | 0.424 | DNA methyltransferase I inhibitor | 0.231 0.055 DBMET00785 0.246 0.049 DBMET00637 0.376 0.011 DBMET00703 0.296 0.028 DBMET00704 0.143 0.112 DBMET03314 0.424 0.007 DBMET03316 0.143 0.112 DBMET03315 | DBMET03316 | |
| 0.054 | 0.025 | 0.089 | Glucose-6-phosphate isomerase inhibitor | 0.07 0.012 DBMET00637 0.044 0.042 DBMET03314 0.089 0.006 DBMET03316 0.044 0.042 DBMET03315 | DBMET03316 | |
| 0.191 | 0.162 | 0.411 | 12-Lipoxygenase inhibitor | 0.266 0.1 DBMET00785 0.411 0.036 DBMET00637 0.223 0.128 DBMET00703 0.301 0.079 DBMET00704 0.249 0.109 DBMET03314 0.249 0.109 DBMET03315 | DBMET00637 | |
| 0.071 | 0.043 | 0.071 | Potassium channel large-conductance Ca-activated activator | |||
| 0.034 | 0.006 | 0.066 | Vanilloid 2 agonist | 0.046 0.003 DBMET00785 0.031 0.008 DBMET03313 0.042 0.004 DBMET00637 0.029 0.011 DBMET00703 0.031 0.008 DBMET00704 0.032 0.008 DBMET03314 0.066 0.002 DBMET03316 0.032 0.008 DBMET03315 | DBMET03316 | |
| 0.075 | 0.048 | 0.173 | Cathepsin G inhibitor | 0.147 0.021 DBMET00785 0.173 0.018 DBMET03313 0.083 0.042 DBMET00637 0.141 0.023 DBMET00703 0.121 0.027 DBMET00704 0.109 0.03 DBMET03314 0.148 0.021 DBMET00784 0.109 0.03 DBMET03315 | DBMET03313 | |
| 0.147 | 0.12 | 0.446 | DNA methylase inhibitor | 0.249 0.049 DBMET00785 0.24 0.054 DBMET00637 0.398 0.011 DBMET00703 0.307 0.026 DBMET00704 0.145 0.121 DBMET03314 0.446 0.008 DBMET03316 0.145 0.121 DBMET03315 | DBMET03316 | |
| 0.059 | 0.032 | 0.07 | Leukotriene C antagonist | 0.054 0.048 DBMET00785 0.07 0.014 DBMET00637 | DBMET00637 | |
| 0.041 | 0.014 | 0.107 | Tryptophan 5 hydroxylase inhibitor | 0.059 0.004 DBMET00785 0.039 0.018 DBMET00637 0.107 0.002 DBMET00703 0.051 0.005 DBMET00704 0.05 0.005 DBMET03314 0.05 0.005 DBMET03315 | DBMET00703 | |
| 0.04 | 0.014 | 0.135 | Catechol O-methyltransferase inhibitor | 0.059 0.007 DBMET00785 0.034 0.021 DBMET03313 0.135 0.004 DBMET00637 0.047 0.01 DBMET00703 0.041 0.013 DBMET00704 0.079 0.005 DBMET03314 0.079 0.005 DBMET03315 | DBMET00637 | |
| 0.117 | 0.091 | 0.138 | Papain-like protease (SARS coronavirus) inhibitor | 0.137 0.049 DBMET00785 0.138 0.047 DBMET00637 0.117 0.09 DBMET00703 0.134 0.054 DBMET00704 0.122 0.077 DBMET03314 0.122 0.077 DBMET03315 | DBMET00637 | |
| 0.112 | 0.086 | 0.215 | Cathepsin H inhibitor | 0.215 0.019 DBMET00785 0.149 0.047 DBMET00637 0.177 0.031 DBMET00703 0.178 0.03 DBMET00704 0.14 0.054 DBMET03314 0.14 0.054 DBMET03315 | DBMET00785 | |
| 0.06 | 0.035 | 0.106 | Maillard reaction inhibitor | 0.088 0.021 DBMET00785 0.085 0.023 DBMET00703 0.065 0.032 DBMET00704 0.106 0.014 DBMET03314 0.106 0.014 DBMET03315 | DBMET03315 | |
| 0.098 | 0.073 | 0.268 | AMP-activated protein kinase stimulant | 0.09 0.085 DBMET00637 0.268 0.006 DBMET03316 | DBMET03316 | |
| 0.046 | 0.021 | 0.108 | Sphingosine kinase 1 inhibitor | 0.108 0.004 DBMET00785 0.055 0.012 DBMET00637 0.039 0.033 DBMET00703 0.059 0.01 DBMET00704 0.064 0.008 DBMET03314 0.064 0.008 DBMET03315 | DBMET00785 | |
| 0.051 | 0.027 | 0.051 | Bombesin antagonist | 0.048 0.032 DBMET00785 | ||
| 0.054 | 0.03 | 0.074 | Lysophosphatidic acid 3 receptor antagonist | 0.066 0.017 DBMET00785 0.06 0.022 DBMET00637 0.074 0.012 DBMET00703 0.058 0.025 DBMET00704 0.058 0.025 DBMET03314 0.058 0.025 DBMET03315 | DBMET00703 | |
| 0.056 | 0.033 | 0.104 | Leukotriene B4 antagonist | 0.054 0.036 DBMET00785 0.061 0.027 DBMET03313 0.065 0.023 DBMET00637 0.065 0.023 DBMET00703 0.055 0.034 DBMET00704 0.064 0.024 DBMET03314 0.104 0.009 DBMET03316 0.057 0.032 DBMET00784 0.064 0.024 DBMET03315 | DBMET03316 | |
| 0.04 | 0.016 | 0.073 | Glutamate (mGluR4) agonist | 0.073 0.006 DBMET00703 | DBMET00703 | |
| 0.078 | 0.054 | 0.261 | Macrophage migration inhibitory factor inhibitor | 0.095 0.038 DBMET00785 0.261 0.005 DBMET00637 0.124 0.024 DBMET00703 0.106 0.031 DBMET00704 | DBMET00637 | |
| 0.038 | 0.015 | 0.038 | Carboxypeptidase B inhibitor | 0.032 0.026 DBMET00785 0.038 0.015 DBMET03313 0.032 0.025 DBMET00784 | ||
| 0.042 | 0.021 | 0.042 | Growth hormone secretagogue receptor agonist | |||
| 0.063 | 0.043 | 0.074 | NMDA receptor glycine site agonist | 0.059 0.047 DBMET00785 0.074 0.033 DBMET00703 | DBMET00703 | |
| 0.107 | 0.087 | 0.124 | Cholinergic antagonist | 0.111 0.083 DBMET00785 0.124 0.07 DBMET03314 0.124 0.07 DBMET03315 | DBMET03315 | |
| 0.026 | 0.007 | 0.026 | Aminopeptidase A inhibitor | 0.024 0.008 DBMET00785 0.016 0.014 DBMET03313 0.019 0.011 DBMET00703 | ||
| 0.059 | 0.04 | 0.093 | Aminopeptidase microsomal inhibitor | 0.093 0.019 DBMET00785 0.081 0.024 DBMET00703 0.07 0.031 DBMET00704 0.081 0.024 DBMET03314 0.081 0.024 DBMET03315 | DBMET00785 | |
| 0.064 | 0.046 | 0.074 | Leukotriene antagonist | 0.074 0.037 DBMET00637 0.066 0.044 DBMET00703 0.063 0.047 DBMET03314 0.064 0.046 DBMET03316 0.063 0.047 DBMET03315 | DBMET00637 | |
| 0.104 | 0.087 | 0.121 | Acetylcholine antagonist | 0.108 0.082 DBMET00785 0.121 0.069 DBMET03314 0.121 0.069 DBMET03315 | DBMET03315 | |
| 0.041 | 0.024 | 0.045 | Glutamate (mGluR group II) antagonist | 0.045 0.02 DBMET00703 | DBMET00703 | |
| 0.034 | 0.019 | 0.049 | ATP citrate lysase inhibitor | 0.049 0.008 DBMET00637 | DBMET00637 | |
| 0.053 | 0.039 | 0.107 | Ribonucleoside-diphosphate reductase inhibitor | 0.107 0.018 DBMET00785 0.062 0.033 DBMET00637 0.099 0.019 DBMET00703 0.059 0.035 DBMET00704 0.065 0.031 DBMET03314 0.065 0.031 DBMET03315 | DBMET00785 | |
| 0.094 | 0.08 | 0.177 | Toll-Like receptor 4 antagonist | 0.106 0.06 DBMET00785 0.107 0.058 DBMET00637 0.136 0.03 DBMET00703 0.116 0.047 DBMET00704 0.097 0.075 DBMET03314 0.177 0.01 DBMET03316 0.097 0.075 DBMET03315 | DBMET03316 | |
| 0.053 | 0.04 | 0.106 | Ribonucleotide reductase inhibitor | 0.106 0.019 DBMET00785 0.063 0.035 DBMET00637 0.098 0.021 DBMET00703 0.06 0.036 DBMET00704 0.067 0.033 DBMET03314 0.067 0.033 DBMET03315 | DBMET00785 | |
| 0.022 | 0.008 | 0.032 | Estrogen-related receptor gamma agonist | 0.028 0.004 DBMET00785 0.032 0.004 DBMET00637 0.019 0.013 DBMET00704 0.017 0.016 DBMET03314 0.017 0.016 DBMET03315 | DBMET00637 | |
| 0.047 | 0.034 | 0.061 | Antimetabolite | 0.048 0.033 DBMET00785 0.061 0.025 DBMET00703 | DBMET00703 | |
| 0.046 | 0.033 | 0.163 | Glycine transporter 2 inhibitor | 0.108 0.012 DBMET00785 0.163 0.007 DBMET00703 0.093 0.014 DBMET00704 0.053 0.029 DBMET03314 0.053 0.029 DBMET03315 | DBMET00703 | |
| 0.035 | 0.023 | 0.035 | Growth factor receptor-bound protein 2 antagonist | 0.033 0.029 DBMET00703 | ||
| 0.055 | 0.044 | 0.069 | Pregnane X receptor antagonist | 0.069 0.015 DBMET00637 0.054 0.048 DBMET03314 0.054 0.048 DBMET03315 | DBMET00637 | |
| 0.07 | 0.06 | 0.116 | Na+ K+ transporting ATPase inhibitor | 0.085 0.046 DBMET00785 0.084 0.046 DBMET03313 0.09 0.041 DBMET00637 0.095 0.036 DBMET03314 0.116 0.019 DBMET03316 0.095 0.036 DBMET03315 | DBMET03316 | |
| 0.108 | 0.098 | 0.191 | Bone formation stimulant | 0.134 0.073 DBMET00785 0.191 0.038 DBMET00703 0.127 0.079 DBMET00704 | DBMET00703 | |
| 0.07 | 0.061 | 0.154 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.07 0.061 DBMET00785 0.154 0.018 DBMET00637 0.088 0.045 DBMET00703 0.077 0.054 DBMET00704 | DBMET00637 | |
| 0.042 | 0.033 | 0.095 | Glutamate (mGluR4) antagonist | 0.058 0.015 DBMET00785 0.095 0.006 DBMET00703 | DBMET00703 | |
| 0.074 | 0.066 | 0.099 | MAP kinase kinase 7 inhibitor | 0.099 0.013 DBMET00785 0.084 0.036 DBMET00637 0.082 0.04 DBMET00704 0.088 0.028 DBMET03314 0.088 0.028 DBMET03315 | DBMET00785 | |
| 0.023 | 0.015 | 0.044 | Glutamate (mGluR1a) agonist | 0.03 0.009 DBMET00785 0.044 0.005 DBMET03313 0.031 0.008 DBMET00703 0.027 0.011 DBMET00784 | DBMET03313 | |
| 0.036 | 0.028 | 0.664 | Cholecystokinin B agonist | 0.664 0.001 DBMET03313 0.616 0.002 DBMET00784 | DBMET03313 | |
| 0.024 | 0.017 | 0.064 | Glutamate (mGluR1) agonist | 0.043 0.005 DBMET00785 0.032 0.009 DBMET03313 0.064 0.004 DBMET00703 | DBMET00703 | |
| 0.014 | 0.006 | 0.026 | Beta 3 adrenoreceptor agonist | 0.026 0.004 DBMET03314 0.026 0.004 DBMET03315 | DBMET03315 | |
| 0.017 | 0.011 | 0.033 | Thyroid hormone alpha agonist | 0.019 0.008 DBMET00785 0.015 0.013 DBMET00637 0.033 0.004 DBMET00703 | DBMET00703 | |
| 0.022 | 0.017 | 0.03 | Prostaglandin F2 alpha agonist | 0.03 0.009 DBMET00637 | DBMET00637 | |
| 0.022 | 0.017 | 0.03 | Isoleucine-tRNA ligase inhibitor | 0.03 0.005 DBMET00785 0.025 0.011 DBMET00703 0.026 0.009 DBMET00704 0.026 0.01 DBMET03314 0.026 0.01 DBMET03315 | DBMET00785 | |
| 0.047 | 0.042 | 0.054 | CD45 antagonist | 0.047 0.043 DBMET00785 0.054 0.029 DBMET00703 | DBMET00703 | |
| 0.055 | 0.051 | 0.055 | Gonadotropin-releasing hormone receptor agonist | |||
| 0.034 | 0.03 | 0.132 | NMDA receptor subunit 3A antagonist | 0.07 0.014 DBMET00785 0.132 0.006 DBMET00703 0.068 0.014 DBMET03314 0.068 0.014 DBMET03315 | DBMET00703 | |
| 0.04 | 0.036 | 0.146 | NMDA receptor subunit 3B antagonist | 0.073 0.015 DBMET00785 0.146 0.006 DBMET00703 0.052 0.024 DBMET03314 0.052 0.024 DBMET03315 | DBMET00703 | |
| 0.118 | 0.114 | 0.513 | Anticoagulant | 0.142 0.087 DBMET00785 0.513 0.009 DBMET03313 0.197 0.054 DBMET00703 0.303 0.028 DBMET03316 0.464 0.012 DBMET00784 | DBMET03313 | |
| 0.037 | 0.033 | 0.046 | Leukotriene C4 antagonist | 0.046 0.014 DBMET00637 | DBMET00637 | |
| 0.085 | 0.081 | 0.253 | Xanthine oxidase inhibitor | 0.108 0.054 DBMET00785 0.123 0.046 DBMET00637 0.14 0.038 DBMET00703 0.102 0.058 DBMET00704 0.096 0.063 DBMET03314 0.253 0.012 DBMET03316 0.096 0.063 DBMET03315 | DBMET03316 | |
| 0.058 | 0.056 | 0.101 | Protease 3C (Human rhinovirus) inhibitor | 0.101 0.015 DBMET00785 0.085 0.023 DBMET00637 0.072 0.034 DBMET00703 0.081 0.026 DBMET00704 | DBMET00785 | |
| 0.149 | 0.146 | 0.326 | Platelet antagonist | 0.17 0.126 DBMET00785 0.177 0.119 DBMET03313 0.326 0.045 DBMET00703 0.309 0.05 DBMET03316 0.16 0.135 DBMET00784 | DBMET00703 | |
| 0.036 | 0.034 | 0.042 | Membrane dipeptidase inhibitor | 0.037 0.031 DBMET00785 0.042 0.024 DBMET03314 0.042 0.024 DBMET03315 | DBMET03315 | |
| 0.066 | 0.064 | 0.167 | CDC25A inhibitor | 0.167 0.01 DBMET03313 0.079 0.044 DBMET00637 0.069 0.059 DBMET00703 0.114 0.021 DBMET00784 | DBMET03313 | |
| 0.036 | 0.035 | 0.058 | AMPA 4 receptor antagonist | 0.054 0.013 DBMET00785 0.058 0.011 DBMET00703 | DBMET00703 | |
| 0.008 | 0.007 | 0.017 | Thyroid hormone beta agonist | 0.01 0.005 DBMET00785 0.009 0.006 DBMET00637 0.017 0.004 DBMET00703 | DBMET00703 | |
| 0.101 | 0.1 | 0.101 | Sphingosine 1-phosphate receptor 2 agonist | |||
| 0.024 | 0.023 | 0.038 | Lysine carboxypeptidase inhibitor | 0.027 0.019 DBMET00785 0.038 0.011 DBMET00703 | DBMET00703 | |
| 0.019 | 0.019 | 0.029 | Neuraminidase (Influenza B) inhibitor | 0.027 0.006 DBMET00785 0.02 0.016 DBMET00637 0.02 0.016 DBMET00704 0.029 0.005 DBMET03314 0.029 0.005 DBMET03315 | DBMET03315 | |
| 0.049 | 0.049 | 0.057 | Bombesin 3 receptor antagonist | 0.057 0.036 DBMET00785 | DBMET00785 | |
| 0.082 | 0.083 | 0.126 | Protease inhibitor | 0.126 0.043 DBMET00785 0.089 0.075 DBMET00637 0.115 0.051 DBMET00703 0.109 0.057 DBMET00704 | DBMET00785 | |
| 0.04 | 0.041 | 0.069 | Aminopeptidase N inhibitor | 0.069 0.02 DBMET00785 0.059 0.025 DBMET00703 0.049 0.032 DBMET00704 0.053 0.029 DBMET03314 0.053 0.029 DBMET03315 | DBMET00785 | |
| 0.038 | 0.04 | 0.061 | Neurotensin receptor antagonist | 0.05 0.028 DBMET00785 0.061 0.023 DBMET00703 0.039 0.038 DBMET00704 | DBMET00703 | |
| 0.015 | 0.016 | 0.023 | Telomerase stimulant | 0.021 0.006 DBMET00785 0.017 0.013 DBMET00637 0.022 0.006 DBMET03314 0.023 0.005 DBMET03316 0.022 0.006 DBMET03315 | DBMET03316 | |
| 0.042 | 0.043 | 0.105 | Carbonic anhydrase XIV inhibitor | 0.056 0.027 DBMET00785 0.06 0.025 DBMET00637 0.087 0.014 DBMET00703 0.067 0.021 DBMET00704 0.105 0.01 DBMET03316 | DBMET03316 | |
| 0.063 | 0.064 | 0.066 | MDM2 inhibitor | 0.066 0.051 DBMET00637 | DBMET00637 | |
| 0.047 | 0.049 | 0.079 | Protein kinase C eta inhibitor | 0.079 0.024 DBMET03314 0.079 0.024 DBMET03315 | DBMET03315 | |
| 0.075 | 0.077 | 0.189 | Opioid antagonist | 0.189 0.016 DBMET00785 0.122 0.035 DBMET00703 0.133 0.031 DBMET00704 0.096 0.051 DBMET03314 0.096 0.051 DBMET03315 | DBMET00785 | |
| 0.025 | 0.027 | 0.033 | Baculoviral IAP repeat-containing protein 4 inhibitor | 0.033 0.011 DBMET00785 0.025 0.024 DBMET00704 0.026 0.022 DBMET03314 0.026 0.022 DBMET03315 | DBMET00785 | |
| 0.014 | 0.016 | 0.029 | Ileal bile acid transport inhibitor | 0.019 0.01 DBMET00703 0.029 0.005 DBMET03314 0.026 0.005 DBMET03316 0.029 0.005 DBMET03315 | DBMET03315 | |
| 0.026 | 0.029 | 0.046 | 1,3-Beta-glucan synthase inhibitor | 0.046 0.003 DBMET03313 0.036 0.005 DBMET03314 0.031 0.014 DBMET03316 0.042 0.004 DBMET00784 0.036 0.005 DBMET03315 | DBMET03313 | |
| 0.013 | 0.016 | 0.023 | Thyroid hormone alpha antagonist | 0.023 0.006 DBMET00703 | DBMET00703 | |
| 0.05 | 0.054 | 0.196 | Opioid delta receptor antagonist | 0.196 0.012 DBMET00785 0.127 0.024 DBMET00703 0.135 0.023 DBMET00704 0.094 0.031 DBMET03314 0.094 0.031 DBMET03315 | DBMET00785 | |
| 0.121 | 0.124 | 0.173 | GABA C receptor rho-2 antagonist | 0.13 0.105 DBMET00785 0.173 0.048 DBMET00637 0.124 0.117 DBMET00704 | DBMET00637 | |
| 0.078 | 0.082 | 0.134 | ATPase (Vacuolar H+) inhibitor | 0.099 0.04 DBMET00637 0.095 0.047 DBMET00703 0.092 0.052 DBMET00704 0.087 0.062 DBMET03314 0.134 0.012 DBMET03316 0.087 0.062 DBMET03315 | DBMET03316 | |
| 0.029 | 0.033 | 0.06 | Phosphoglycerate kinase inhibitor | 0.037 0.022 DBMET00785 0.031 0.029 DBMET03313 0.06 0.011 DBMET00637 0.036 0.023 DBMET00703 0.042 0.018 DBMET00704 0.04 0.019 DBMET03314 0.032 0.028 DBMET00784 0.04 0.019 DBMET03315 | DBMET00637 | |
| 0.048 | 0.053 | 0.062 | Angiotensin-converting enzyme inhibitor | 0.059 0.032 DBMET00785 0.062 0.027 DBMET00703 | DBMET00703 | |
| 0.022 | 0.026 | 0.036 | Uridine phosphorylase inhibitor | 0.036 0.014 DBMET00637 0.027 0.02 DBMET03316 | DBMET00637 | |
| 0.081 | 0.086 | 0.2 | Sphingomyelinase inhibitor | 0.133 0.033 DBMET00785 0.117 0.043 DBMET00637 0.111 0.048 DBMET00703 0.157 0.022 DBMET00704 0.2 0.01 DBMET03314 0.098 0.062 DBMET03316 0.2 0.01 DBMET03315 | DBMET03315 | |
| 0.014 | 0.019 | 0.03 | Nicotinic acid receptor 1 antagonist | 0.03 0.004 DBMET00785 0.021 0.008 DBMET00637 | DBMET00785 | |
| 0.004 | 0.009 | 0.006 | Insulin like growth factor 3 antagonist | 0.006 0.005 DBMET00637 | DBMET00637 | |
| 0.098 | 0.103 | 0.152 | Estrogen antagonist | 0.115 0.064 DBMET00785 0.152 0.022 DBMET00637 0.1 0.099 DBMET00704 0.1 0.098 DBMET03314 0.105 0.086 DBMET03316 0.1 0.098 DBMET03315 | DBMET00637 | |
| 0.028 | 0.034 | 0.032 | Retinoid X alpha receptor agonist | 0.032 0.028 DBMET00637 | DBMET00637 | |
| 0.041 | 0.046 | 0.118 | NMDA 2A receptor antagonist | 0.088 0.017 DBMET00785 0.108 0.011 DBMET00703 0.118 0.01 DBMET03314 0.118 0.01 DBMET03315 | DBMET03315 | |
| 0.015 | 0.021 | 0.109 | Tryptophan hydroxylase 1 inhibitor | 0.024 0.004 DBMET00785 0.109 0.002 DBMET00703 0.021 0.005 DBMET00704 0.022 0.005 DBMET03314 0.022 0.005 DBMET03315 | DBMET00703 | |
| 0.026 | 0.032 | 0.044 | Calcitonin receptor agonist | 0.044 0.018 DBMET00785 0.03 0.027 DBMET00703 0.035 0.023 DBMET03314 0.035 0.023 DBMET03315 | DBMET00785 | |
| 0.037 | 0.044 | 0.055 | Adenosine deaminase inhibitor | 0.055 0.026 DBMET00785 0.041 0.039 DBMET00637 | DBMET00785 | |
| 0.022 | 0.028 | 0.111 | Sodium/glucose cotransporter 2 inhibitor | 0.028 0.016 DBMET00637 0.111 0.002 DBMET03316 | DBMET03316 | |
| 0.033 | 0.04 | 0.065 | Oxytocin agonist | 0.065 0.013 DBMET00785 0.048 0.025 DBMET00637 0.046 0.027 DBMET00704 0.047 0.026 DBMET03314 0.047 0.026 DBMET03315 | DBMET00785 | |
| 0.036 | 0.044 | 0.058 | VCAM-1 antagonist | 0.041 0.021 DBMET00785 0.058 0.006 DBMET00703 0.039 0.028 DBMET00704 | DBMET00703 | |
| 0.036 | 0.044 | 0.058 | VCAM antagonist | 0.041 0.021 DBMET00785 0.058 0.006 DBMET00703 0.039 0.028 DBMET00704 | DBMET00703 | |
| 0.051 | 0.059 | 0.105 | NMDA 2C receptor antagonist | 0.083 0.023 DBMET00785 0.099 0.016 DBMET00703 0.105 0.014 DBMET03314 0.105 0.014 DBMET03315 | DBMET03315 | |
| 0.041 | 0.05 | 0.119 | Aldose reductase inhibitor | 0.067 0.028 DBMET03313 0.057 0.034 DBMET00637 0.049 0.04 DBMET00703 0.119 0.014 DBMET03316 | DBMET03316 | |
| 0.048 | 0.057 | 0.09 | Dihydroorotate oxidase inhibitor | 0.054 0.04 DBMET00785 0.09 0.007 DBMET00637 0.051 0.048 DBMET03314 0.051 0.048 DBMET03315 | DBMET00637 | |
| 0.046 | 0.056 | 0.059 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.059 0.036 DBMET00637 0.055 0.04 DBMET03316 | DBMET00637 | |
| 0.044 | 0.054 | 0.064 | Factor III inhibitor | 0.05 0.034 DBMET00785 0.053 0.027 DBMET00637 0.052 0.03 DBMET00703 0.054 0.026 DBMET00704 0.05 0.033 DBMET03314 0.064 0.014 DBMET03316 0.05 0.033 DBMET03315 | DBMET03316 | |
| 0.065 | 0.075 | 0.107 | Metalloproteinase-2 inhibitor | 0.088 0.045 DBMET00785 0.107 0.035 DBMET00703 0.078 0.055 DBMET00704 | DBMET00703 | |
| 0.08 | 0.09 | 0.157 | Urease inhibitor | 0.129 0.037 DBMET00785 0.15 0.023 DBMET00637 0.124 0.041 DBMET00703 0.127 0.039 DBMET00704 0.157 0.02 DBMET03314 0.157 0.02 DBMET03315 | DBMET03315 | |
| 0.054 | 0.064 | 0.084 | Peroxisome proliferator-activated receptor gamma agonist | 0.066 0.053 DBMET00637 0.084 0.038 DBMET00703 | DBMET00703 | |
| 0.053 | 0.063 | 0.076 | Matrix metalloproteinase inhibitor | 0.069 0.045 DBMET00785 0.076 0.039 DBMET00703 0.062 0.051 DBMET00704 | DBMET00703 | |
| 0.016 | 0.026 | 0.038 | Antibiotic Anthracycline-like | 0.021 0.009 DBMET00785 0.023 0.006 DBMET00637 0.018 0.015 DBMET00703 0.022 0.008 DBMET00704 0.023 0.006 DBMET03314 0.038 0.002 DBMET03316 0.023 0.006 DBMET03315 | DBMET03316 | |
| 0.044 | 0.055 | 0.156 | Glucose-6-phosphate translocase inhibitor | 0.061 0.023 DBMET00785 0.143 0.004 DBMET00637 0.07 0.016 DBMET00703 0.073 0.014 DBMET00704 0.05 0.039 DBMET03314 0.156 0.003 DBMET03316 0.05 0.039 DBMET03315 | DBMET03316 | |
| 0.027 | 0.038 | 0.036 | Free fatty acid receptor 1 antagonist | 0.036 0.02 DBMET00637 | DBMET00637 | |
| 0.198 | 0.21 | 0.811 | Antiobesity | 0.274 0.136 DBMET00785 0.346 0.089 DBMET03313 0.811 0.005 DBMET03314 0.287 0.126 DBMET00784 0.811 0.005 DBMET03315 | DBMET03315 | |
| 0.021 | 0.033 | 0.099 | Sodium/glucose cotransporter inhibitor | 0.026 0.018 DBMET00637 0.099 0.003 DBMET03316 | DBMET03316 | |
| 0.052 | 0.063 | 0.166 | Opioid mu receptor antagonist | 0.166 0.014 DBMET00785 0.102 0.031 DBMET00703 0.109 0.028 DBMET00704 0.079 0.04 DBMET03314 0.079 0.04 DBMET03315 | DBMET00785 | |
| 0.02 | 0.032 | 0.023 | Lysophosphatidic acid receptor 1 agonist | 0.023 0.02 DBMET03314 0.023 0.02 DBMET03315 | DBMET03315 | |
| 0.084 | 0.096 | 0.148 | Estrogen receptor beta antagonist | 0.105 0.055 DBMET00785 0.148 0.016 DBMET00637 0.088 0.087 DBMET00704 0.09 0.083 DBMET03314 0.09 0.083 DBMET03315 | DBMET00637 | |
| 0.017 | 0.03 | 0.036 | Dopamine D1 agonist | 0.032 0.008 DBMET00785 0.036 0.006 DBMET03313 0.027 0.011 DBMET00637 0.025 0.013 DBMET00704 0.022 0.017 DBMET03314 0.033 0.008 DBMET03316 0.022 0.017 DBMET03315 | DBMET03313 | |
| 0.036 | 0.049 | 0.045 | AICAR transformylase inhibitor | 0.045 0.028 DBMET00703 | DBMET00703 | |
| 0.049 | 0.062 | 0.367 | Selectin antagonist | 0.084 0.035 DBMET00785 0.209 0.01 DBMET03313 0.084 0.035 DBMET00703 0.081 0.036 DBMET03314 0.367 0.004 DBMET03316 0.16 0.016 DBMET00784 0.081 0.036 DBMET03315 | DBMET03316 | |
| 0.081 | 0.094 | 0.089 | Electrolyte absorption antagonist | 0.089 0.075 DBMET00637 | DBMET00637 | |
| 0.006 | 0.021 | 0.013 | Thromboxane agonist | 0.013 0.005 DBMET00637 | DBMET00637 | |
| 0.089 | 0.103 | 0.214 | Alkylator | 0.131 0.059 DBMET00785 0.214 0.023 DBMET00703 0.137 0.054 DBMET00704 0.145 0.049 DBMET03314 0.194 0.028 DBMET03316 0.145 0.049 DBMET03315 | DBMET00703 | |
| 0.05 | 0.065 | 0.078 | Neutrophil collagenase inhibitor | 0.078 0.033 DBMET00785 0.076 0.035 DBMET00703 0.063 0.047 DBMET00704 | DBMET00785 | |
| 0.052 | 0.067 | 0.064 | Ryanodine receptor antagonist | 0.064 0.027 DBMET00637 0.063 0.029 DBMET00703 0.061 0.035 DBMET00704 | DBMET00637 | |
| 0.053 | 0.068 | 0.159 | Leukotriene synthesis inhibitor | 0.159 0.008 DBMET00637 0.065 0.048 DBMET03316 | DBMET00637 | |
| 0.054 | 0.07 | 0.064 | Trypsin inhibitor | 0.064 0.039 DBMET00785 0.058 0.055 DBMET03313 0.061 0.046 DBMET00703 | DBMET00785 | |
| 0.076 | 0.092 | 0.15 | Thioredoxin inhibitor | 0.129 0.025 DBMET00637 0.089 0.063 DBMET00703 0.15 0.017 DBMET03316 | DBMET03316 | |
| 0.023 | 0.039 | 0.033 | Purinergic P2Y15 antagonist | 0.03 0.017 DBMET00785 0.026 0.025 DBMET00637 0.033 0.012 DBMET03314 0.033 0.012 DBMET03315 | DBMET03315 | |
| 0.011 | 0.028 | 0.015 | Purinergic P2Y1 agonist | 0.015 0.012 DBMET00785 | DBMET00785 | |
| 0.054 | 0.071 | 0.131 | Neuraminidase (influenza) inhibitor | 0.071 0.034 DBMET00785 0.089 0.02 DBMET03313 0.06 0.054 DBMET00703 0.062 0.049 DBMET00704 0.131 0.01 DBMET03314 0.108 0.014 DBMET03316 0.068 0.037 DBMET00784 0.131 0.01 DBMET03315 | DBMET03315 | |
| 0.008 | 0.027 | 0.016 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | 0.012 0.01 DBMET00785 0.016 0.005 DBMET00637 | DBMET00637 | |
| 0.059 | 0.078 | 0.091 | Glutamate receptor agonist | 0.091 0.044 DBMET00703 | DBMET00703 | |
| 0.033 | 0.053 | 0.055 | Geranyltranstransferase inhibitor | 0.055 0.017 DBMET00785 0.047 0.026 DBMET00637 | DBMET00785 | |
| 0.045 | 0.065 | 0.113 | Neuraminidase inhibitor | 0.066 0.037 DBMET00785 0.073 0.031 DBMET03313 0.113 0.011 DBMET03314 0.094 0.018 DBMET03316 0.113 0.011 DBMET03315 | DBMET03315 | |
| 0.023 | 0.043 | 0.035 | Estrogen-related receptor gamma antagonist | 0.031 0.014 DBMET00785 0.035 0.008 DBMET00637 0.027 0.023 DBMET03314 0.027 0.023 DBMET03315 | DBMET00637 | |
| 0.021 | 0.043 | 0.083 | Kainate receptor 2 antagonist | 0.051 0.016 DBMET00785 0.083 0.006 DBMET00703 | DBMET00703 | |
| 0.045 | 0.066 | 0.067 | Epithelial sodium channel blocker | 0.067 0.021 DBMET00785 0.053 0.043 DBMET00704 | DBMET00785 | |
| 0.027 | 0.049 | 0.052 | Toll-Like receptor 2 agonist | 0.052 0.022 DBMET00785 0.046 0.025 DBMET00703 0.045 0.026 DBMET03314 0.045 0.026 DBMET03315 | DBMET00785 | |
| 0.084 | 0.107 | 0.147 | Folate antagonist | 0.093 0.079 DBMET00785 0.147 0.023 DBMET00703 | DBMET00703 | |
| 0.064 | 0.087 | 0.137 | Estrogen receptor alpha antagonist | 0.074 0.059 DBMET00785 0.137 0.014 DBMET00637 | DBMET00637 | |
| 0.035 | 0.058 | 0.061 | Neuraminidase (Influenza A) inhibitor | 0.051 0.023 DBMET00785 0.044 0.034 DBMET00704 0.061 0.012 DBMET03314 0.056 0.017 DBMET03316 0.061 0.012 DBMET03315 | DBMET03315 | |
| 0.034 | 0.059 | 0.081 | Neuropeptide agonist | 0.081 0.031 DBMET00785 0.047 0.044 DBMET00704 0.075 0.033 DBMET03314 0.075 0.033 DBMET03315 | DBMET00785 | |
| 0.012 | 0.038 | 0.016 | Antibiotic Tetracycline-like | 0.016 0.008 DBMET00637 | DBMET00637 | |
| 0.029 | 0.056 | 0.043 | Liver X receptor alpha agonist | 0.043 0.026 DBMET00637 | DBMET00637 | |
| 0.03 | 0.057 | 0.045 | HIV-1 protease inhibitor | 0.045 0.027 DBMET00785 | DBMET00785 | |
| 0.023 | 0.051 | 0.035 | Dipeptidyl peptidase II inhibitor | 0.035 0.019 DBMET00785 | DBMET00785 | |
| 0.014 | 0.041 | 0.02 | Leukotriene B4 receptor 2 antagonist | 0.02 0.018 DBMET03316 | DBMET03316 | |
| 0.075 | 0.102 | 0.197 | Falcipain 3 inhibitor | 0.197 0.019 DBMET00785 0.155 0.034 DBMET00637 0.155 0.034 DBMET00703 0.188 0.021 DBMET00704 0.092 0.078 DBMET03314 0.092 0.078 DBMET03315 | DBMET00785 | |
| 0.078 | 0.106 | 0.196 | Protein-tyrosine phosphatase 1B inhibitor | 0.102 0.076 DBMET00785 0.196 0.03 DBMET03313 0.118 0.065 DBMET00637 0.173 0.037 DBMET00703 0.153 0.044 DBMET03316 0.145 0.048 DBMET00784 | DBMET03313 | |
| 0.059 | 0.087 | 0.101 | Calcium antagonist | 0.092 0.053 DBMET00637 0.101 0.047 DBMET00704 | DBMET00704 | |
| 0.048 | 0.075 | 0.078 | Immunoglobulin Fc receptor antagonist | 0.078 0.007 DBMET00785 0.059 0.026 DBMET00637 0.056 0.034 DBMET00703 0.067 0.014 DBMET00704 | DBMET00785 | |
| 0.049 | 0.077 | 0.072 | Lipocortins synthesis agonist | 0.058 0.039 DBMET00637 0.072 0.019 DBMET03316 | DBMET03316 | |
| 0.082 | 0.111 | 0.165 | Nav1.4 sodium channel blocker | 0.16 0.03 DBMET00785 0.135 0.041 DBMET03313 0.129 0.045 DBMET00703 0.127 0.047 DBMET00704 0.165 0.028 DBMET03314 0.117 0.055 DBMET00784 0.165 0.028 DBMET03315 | DBMET03315 | |
| 0.039 | 0.069 | 0.087 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.053 0.038 DBMET00785 0.087 0.014 DBMET00637 | DBMET00637 | |
| 0.008 | 0.04 | 0.073 | Integrin alpha4beta7 antagonist | 0.018 0.017 DBMET00785 0.073 0.004 DBMET00703 | DBMET00703 | |
| 0.062 | 0.094 | 0.109 | Opioid kappa receptor antagonist | 0.109 0.029 DBMET00785 0.079 0.06 DBMET00703 0.085 0.051 DBMET00704 | DBMET00785 | |
| 0.042 | 0.075 | 0.082 | Bombesin 1 receptor agonist | 0.082 0.024 DBMET00785 0.073 0.03 DBMET00704 | DBMET00785 | |
| 0.111 | 0.144 | 0.42 | Amyloid beta aggregation inhibitor | 0.379 0.028 DBMET00785 0.351 0.034 DBMET00637 0.397 0.025 DBMET00703 0.42 0.022 DBMET00704 0.285 0.048 DBMET03314 0.262 0.054 DBMET03316 0.285 0.048 DBMET03315 | DBMET00704 | |
| 0.069 | 0.103 | 0.181 | Transcription factor NF kappa B stimulant | 0.093 0.046 DBMET00785 0.084 0.061 DBMET00637 0.088 0.053 DBMET00703 0.088 0.054 DBMET00704 0.092 0.048 DBMET03314 0.181 0.011 DBMET03316 0.092 0.048 DBMET03315 | DBMET03316 | |
| 0.014 | 0.048 | 0.043 | AMPA 3 receptor antagonist | 0.036 0.016 DBMET00785 0.043 0.012 DBMET00703 | DBMET00703 | |
| 0.021 | 0.055 | 0.065 | Complement C3a chemotactic receptor antagonist | 0.043 0.031 DBMET00785 0.065 0.019 DBMET00703 | DBMET00703 | |
| 0.026 | 0.061 | 0.036 | GABA uptake inhibitor | 0.036 0.032 DBMET00637 | DBMET00637 | |
| 0.025 | 0.06 | 0.037 | Dihydropteroate synthase inhibitor | 0.037 0.031 DBMET00703 | DBMET00703 | |
| 0.094 | 0.129 | 0.22 | Alkaline phosphatase inhibitor | 0.15 0.06 DBMET00785 0.136 0.07 DBMET03313 0.147 0.061 DBMET00637 0.22 0.027 DBMET00703 0.159 0.054 DBMET00704 0.158 0.055 DBMET03316 0.11 0.099 DBMET00784 | DBMET00703 | |
| 0.057 | 0.092 | 0.161 | Somatostatin 1 agonist | 0.154 0.013 DBMET00785 0.086 0.045 DBMET00703 0.115 0.026 DBMET00704 0.161 0.011 DBMET03314 0.161 0.011 DBMET03315 | DBMET03315 | |
| 0.009 | 0.045 | 0.12 | VLA-4 antagonist | 0.024 0.019 DBMET00785 0.12 0.005 DBMET00703 | DBMET00703 | |
| 0.008 | 0.044 | 0.077 | Integrin beta7 antagonist | 0.077 0.005 DBMET00703 | DBMET00703 | |
| 0.032 | 0.068 | 0.052 | Dihydrofolate reductase inhibitor | 0.051 0.018 DBMET00703 0.052 0.016 DBMET00784 | DBMET00784 | |
| 0.019 | 0.057 | 0.042 | Lysophosphatidic acid 2 receptor antagonist | 0.038 0.013 DBMET00785 0.029 0.023 DBMET00637 0.033 0.018 DBMET00703 0.034 0.017 DBMET00704 0.042 0.011 DBMET03314 0.042 0.011 DBMET03315 | DBMET03315 | |
| 0.011 | 0.05 | 0.033 | Aminopeptidase P inhibitor | 0.033 0.008 DBMET00785 0.024 0.015 DBMET00704 0.022 0.017 DBMET03314 0.022 0.017 DBMET03315 | DBMET00785 | |
| 0.108 | 0.147 | 0.205 | Thiol protease inhibitor | 0.205 0.037 DBMET00785 0.171 0.054 DBMET00637 0.161 0.06 DBMET00703 0.163 0.059 DBMET00704 0.144 0.075 DBMET03314 0.144 0.075 DBMET03315 | DBMET00785 | |
| 0.06 | 0.099 | 0.122 | Glycine receptor antagonist | 0.098 0.034 DBMET03313 0.08 0.057 DBMET00637 0.122 0.017 DBMET03316 0.083 0.052 DBMET00784 | DBMET03316 | |
| 0.057 | 0.096 | 0.088 | Peroxisome proliferator-activated receptor gamma antagonist | 0.074 0.045 DBMET00637 0.088 0.025 DBMET00703 | DBMET00703 | |
| 0.006 | 0.046 | 0.04 | Kainate receptor 1 antagonist | 0.02 0.015 DBMET00785 0.04 0.007 DBMET00703 | DBMET00703 | |
| 0.016 | 0.057 | 0.023 | ICAM 1 antagonist | 0.022 0.018 DBMET00785 0.023 0.015 DBMET00703 | DBMET00703 | |
| 0.006 | 0.047 | 0.011 | Calcium-dependent phospholipase A2 inhibitor | 0.011 0.01 DBMET00637 | DBMET00637 | |
| 0.026 | 0.067 | 0.12 | Phosphorylase inhibitor | 0.046 0.033 DBMET00637 0.073 0.019 DBMET00703 0.12 0.01 DBMET03316 | DBMET03316 | |
| 0.036 | 0.078 | 0.082 | Topoisomerase II beta inhibitor | 0.082 0.013 DBMET00637 0.061 0.021 DBMET03316 | DBMET00637 | |
| 0.06 | 0.102 | 0.122 | Myeloperoxidase inhibitor | 0.11 0.026 DBMET00785 0.094 0.043 DBMET00637 0.122 0.019 DBMET00703 0.11 0.026 DBMET00704 0.082 0.063 DBMET03314 0.082 0.063 DBMET03315 | DBMET00703 | |
| 0.016 | 0.058 | 0.037 | Prostaglandin agonist | 0.037 0.015 DBMET00637 | DBMET00637 | |
| 0.032 | 0.074 | 0.046 | Plasminogen activator inhibitor antagonist | 0.046 0.037 DBMET00703 | DBMET00703 | |
| 0.07 | 0.113 | 0.093 | Polo-like kinase-1 inhibitor | 0.093 0.056 DBMET00703 0.089 0.063 DBMET00704 | DBMET00703 | |
| 0.025 | 0.068 | 0.044 | Growth hormone release inhibitor | 0.044 0.027 DBMET00785 0.042 0.029 DBMET03314 0.042 0.029 DBMET03315 | DBMET00785 | |
| 0.027 | 0.071 | 0.057 | Matrix metalloproteinase 1 inhibitor | 0.057 0.033 DBMET00785 0.055 0.035 DBMET00703 0.053 0.036 DBMET00704 | DBMET00785 | |
| 0.024 | 0.067 | 0.039 | Erythropoietin receptor agonist | 0.038 0.031 DBMET00785 0.039 0.03 DBMET00703 | DBMET00703 | |
| 0.008 | 0.051 | 0.661 | Cholecystokinin agonist | 0.661 0.002 DBMET03313 0.609 0.002 DBMET00784 | DBMET03313 | |
| 0.044 | 0.088 | 0.07 | Heat shock protein 90 beta antagonist | 0.07 0.028 DBMET00785 0.059 0.042 DBMET00637 0.068 0.03 DBMET00704 | DBMET00785 | |
| 0.019 | 0.065 | 0.112 | Kainate receptor antagonist | 0.052 0.02 DBMET00785 0.112 0.006 DBMET00703 | DBMET00703 | |
| 0.04 | 0.086 | 0.08 | Botulinum neurotoxin type A inhibitor | 0.08 0.017 DBMET00785 0.061 0.037 DBMET00703 0.059 0.04 DBMET00704 0.065 0.031 DBMET03314 0.065 0.031 DBMET03315 | DBMET00785 | |
| 0.037 | 0.083 | 0.056 | Matrix metalloproteinase (membrane-type) inhibitor | 0.052 0.043 DBMET00785 0.056 0.036 DBMET00703 | DBMET00703 | |
| 0.027 | 0.073 | 0.043 | Calcium-independent phospholipase A2 inhibitor | 0.043 0.007 DBMET00637 | DBMET00637 | |
| 0.03 | 0.078 | 0.051 | Xanthine dehydrogenase inhibitor | 0.051 0.045 DBMET00637 | DBMET00637 | |
| 0.054 | 0.102 | 0.089 | Metalloproteinase-9 inhibitor | 0.079 0.044 DBMET00785 0.089 0.038 DBMET00703 0.074 0.05 DBMET00704 | DBMET00703 | |
| 0.02 | 0.069 | 0.098 | Diamine oxidase inhibitor | 0.049 0.015 DBMET00785 0.038 0.026 DBMET00637 0.046 0.018 DBMET00704 0.098 0.004 DBMET03314 0.098 0.004 DBMET03315 | DBMET03315 | |
| 0.185 | 0.234 | 0.557 | Alpha-glucosidase inhibitor | 0.557 0.064 DBMET03316 | DBMET03316 | |
| 0.01 | 0.06 | 0.019 | Integrin alphaVbeta1 antagonist | 0.019 0.013 DBMET00703 | DBMET00703 | |
| 0.009 | 0.058 | 0.021 | Prostaglandin E2 agonist | 0.021 0.019 DBMET00637 | DBMET00637 | |
| 0.036 | 0.086 | 0.065 | Squalene epoxidase inhibitor | 0.048 0.038 DBMET00785 0.065 0.017 DBMET00637 | DBMET00637 | |
| 0.046 | 0.097 | 0.069 | Protein kinase C beta inhibitor | 0.069 0.049 DBMET03314 0.069 0.049 DBMET03315 | DBMET03315 | |
| 0.084 | 0.135 | 0.357 | Cell adhesion inhibitor | 0.13 0.058 DBMET00785 0.357 0.007 DBMET00703 0.133 0.057 DBMET00704 0.307 0.01 DBMET03316 | DBMET00703 | |
| 0.022 | 0.073 | 0.051 | Ceramide glucosyltransferase inhibitor | 0.033 0.029 DBMET00785 0.051 0.006 DBMET03314 0.051 0.006 DBMET03315 | DBMET03315 | |
| 0.12 | 0.171 | 0.514 | Non-steroidal antiinflammatory agent | 0.215 0.06 DBMET00785 0.216 0.059 DBMET00637 0.244 0.045 DBMET00703 0.244 0.045 DBMET00704 0.514 0.006 DBMET03316 | DBMET03316 | |
| 0.008 | 0.06 | 0.125 | Integrin alpha4 antagonist | 0.125 0.005 DBMET00703 | DBMET00703 | |
| 0.043 | 0.095 | 0.095 | CDC25B inhibitor | 0.076 0.031 DBMET00637 0.058 0.054 DBMET00703 0.095 0.018 DBMET03314 0.095 0.018 DBMET03315 | DBMET03315 | |
| 0.019 | 0.071 | 0.046 | GP IIb/IIIa receptor antagonist | 0.046 0.036 DBMET00703 | DBMET00703 | |
| 0.045 | 0.099 | 0.093 | Sirtuin 1 inhibitor | 0.093 0.026 DBMET00785 0.083 0.033 DBMET00703 0.072 0.043 DBMET00704 0.071 0.043 DBMET03314 0.071 0.043 DBMET03315 | DBMET00785 | |
| 0.02 | 0.075 | 0.046 | Urokinase inhibitor | 0.046 0.034 DBMET00785 | DBMET00785 | |
| 0.034 | 0.089 | 0.075 | Acetylcholine M3 receptor antagonist | 0.075 0.028 DBMET03314 0.075 0.028 DBMET03315 | DBMET03315 | |
| 0.007 | 0.066 | 0.053 | Estrogen receptor alpha agonist | 0.053 0.016 DBMET00637 | DBMET00637 | |
| 0.046 | 0.106 | 0.061 | Interferon inducer | 0.059 0.057 DBMET00785 0.06 0.053 DBMET03314 0.061 0.05 DBMET03316 0.06 0.053 DBMET03315 | DBMET03316 | |
| 0.02 | 0.081 | 0.04 | Macrophage elastase inhibitor | 0.04 0.033 DBMET00703 | DBMET00703 | |
| 0.008 | 0.07 | 0.046 | Estrogen receptor beta agonist | 0.045 0.02 DBMET03313 0.046 0.02 DBMET00637 | DBMET00637 | |
| 0.019 | 0.081 | 0.027 | Hedgehog signaling activator | 0.027 0.019 DBMET00637 | DBMET00637 | |
| 0.008 | 0.071 | 0.023 | Estradiol 17 beta-dehydrogenase 1 inhibitor | 0.023 0.015 DBMET00637 | DBMET00637 | |
| 0.086 | 0.149 | 0.199 | Histone deacetylase SIRT1 inhibitor | 0.199 0.031 DBMET00785 0.17 0.047 DBMET00703 0.158 0.055 DBMET00704 0.127 0.083 DBMET03314 0.127 0.083 DBMET03315 | DBMET00785 | |
| 0.035 | 0.098 | 0.05 | Carbonic anhydrase II stimulant | 0.05 0.04 DBMET00703 | DBMET00703 | |
| 0.028 | 0.091 | 0.062 | Adenylate cyclase 1 inhibitor | 0.062 0.017 DBMET00637 | DBMET00637 | |
| 0.004 | 0.067 | 0.023 | Integrin alpha4beta1 antagonist | 0.023 0.008 DBMET00703 | DBMET00703 | |
| 0.054 | 0.117 | 0.156 | NMDA receptor antagonist | 0.143 0.027 DBMET00785 0.139 0.028 DBMET00703 0.156 0.022 DBMET03314 0.156 0.022 DBMET03315 | DBMET03315 | |
| 0.047 | 0.111 | 0.059 | Heme oxygenase stimulant | 0.059 0.048 DBMET00637 | DBMET00637 | |
| 0.028 | 0.091 | 0.096 | Alpha tubulin antagonist | 0.047 0.044 DBMET00785 0.096 0.016 DBMET00637 0.068 0.025 DBMET00703 0.094 0.016 DBMET00704 | DBMET00637 | |
| 0.063 | 0.127 | 0.147 | Uric acid excretion stimulant | 0.093 0.06 DBMET00637 0.147 0.024 DBMET03316 | DBMET03316 | |
| 0.104 | 0.168 | 0.501 | Platelet adhesion inhibitor | 0.162 0.094 DBMET00785 0.31 0.031 DBMET03313 0.344 0.021 DBMET00637 0.288 0.038 DBMET00703 0.187 0.078 DBMET00704 0.134 0.126 DBMET03314 0.501 0.005 DBMET03316 0.293 0.036 DBMET00784 0.134 0.126 DBMET03315 | DBMET03316 | |
| 0.051 | 0.115 | 0.075 | Exportin-1 inhibitor | 0.075 0.033 DBMET00637 0.064 0.058 DBMET03314 0.064 0.058 DBMET03315 | DBMET00637 | |
| 0.009 | 0.074 | 0.05 | Squalene synthetase inhibitor | 0.05 0.014 DBMET03316 | DBMET03316 | |
| 0.033 | 0.098 | 0.049 | CXC chemokine 1 receptor antagonist | 0.049 0.039 DBMET00637 | DBMET00637 | |
| 0.059 | 0.125 | 0.324 | Mediator release inhibitor | 0.122 0.046 DBMET00637 0.098 0.072 DBMET00703 0.324 0.006 DBMET03316 | DBMET03316 | |
| 0.035 | 0.101 | 0.23 | Heparanase inhibitor | 0.06 0.023 DBMET03313 0.066 0.015 DBMET00637 0.051 0.044 DBMET00703 0.23 0.002 DBMET03316 0.066 0.015 DBMET00784 | DBMET03316 | |
| 0.026 | 0.092 | 0.07 | Plasminogen activator inhibitor | 0.07 0.032 DBMET00785 | DBMET00785 | |
| 0.036 | 0.102 | 0.055 | Nicotinic alpha3beta2 receptor antagonist | 0.055 0.033 DBMET00785 | DBMET00785 | |
| 0.135 | 0.201 | 0.28 | Calpain inhibitor | 0.28 0.041 DBMET00785 0.246 0.068 DBMET00637 0.243 0.071 DBMET00703 0.259 0.057 DBMET00704 0.25 0.065 DBMET03314 0.25 0.065 DBMET03315 | DBMET00785 | |
| 0.013 | 0.08 | 0.025 | Nicotinic acid receptor 2 antagonist | 0.025 0.021 DBMET00637 | DBMET00637 | |
| 0.03 | 0.096 | 0.06 | Human rhinovirus A protease inhibitor | 0.06 0.035 DBMET00785 0.052 0.041 DBMET00637 | DBMET00785 | |
| 0.005 | 0.075 | 0.029 | AMPA 1 receptor antagonist | 0.029 0.021 DBMET00703 | DBMET00703 | |
| 0.052 | 0.121 | 0.08 | Interferon agonist | 0.072 0.066 DBMET00785 0.074 0.062 DBMET03314 0.08 0.053 DBMET03316 0.074 0.062 DBMET03315 | DBMET03316 | |
| 0.051 | 0.121 | 0.12 | Histamine N-methyltransferase inhibitor | 0.12 0.03 DBMET00785 0.076 0.071 DBMET00637 | DBMET00785 | |
| 0.023 | 0.093 | 0.123 | Opioid mu receptor agonist | 0.123 0.009 DBMET00785 0.043 0.037 DBMET00637 0.062 0.023 DBMET00703 0.077 0.018 DBMET00704 0.05 0.029 DBMET03314 0.05 0.029 DBMET03315 | DBMET00785 | |
| 0.012 | 0.082 | 0.055 | Protein 30S ribosomal subunit inhibitor | 0.055 0.007 DBMET03316 | DBMET03316 | |
| 0.016 | 0.087 | 0.104 | Estrogen agonist | 0.104 0.016 DBMET03313 0.079 0.023 DBMET00637 0.079 0.023 DBMET03316 0.058 0.031 DBMET00784 | DBMET03313 | |
| 0.051 | 0.122 | 0.072 | Calcium channel P-type blocker | 0.066 0.037 DBMET00637 0.06 0.057 DBMET00703 0.072 0.024 DBMET00704 | DBMET00704 | |
| 0.078 | 0.149 | 0.114 | M17 leucyl aminopeptidase inhibitor | 0.114 0.084 DBMET00703 | DBMET00703 | |
| 0.095 | 0.167 | 0.357 | Hexokinase inhibitor | 0.219 0.026 DBMET00637 0.137 0.095 DBMET00703 0.357 0.006 DBMET03316 | DBMET03316 | |
| 0.021 | 0.093 | 0.044 | Integrin alpha5beta1 antagonist | 0.044 0.024 DBMET00703 | DBMET00703 | |
| 0.012 | 0.084 | 0.041 | Sirtuin 2 inhibitor | 0.041 0.017 DBMET00785 | DBMET00785 | |
| 0.081 | 0.154 | 0.13 | Nav1.2 sodium channel blocker | 0.13 0.072 DBMET00785 0.111 0.095 DBMET00704 | DBMET00785 | |
| 0.064 | 0.137 | 0.129 | Lanosterol 14 alpha demethylase inhibitor | 0.109 0.042 DBMET00785 0.129 0.022 DBMET00637 0.102 0.053 DBMET03314 0.102 0.053 DBMET03315 | DBMET00637 | |
| 0.08 | 0.154 | 0.192 | NADPH oxidase inhibitor | 0.131 0.07 DBMET00785 0.131 0.07 DBMET00637 0.192 0.037 DBMET00703 0.166 0.046 DBMET00704 0.124 0.078 DBMET03314 0.135 0.066 DBMET03316 0.124 0.078 DBMET03315 | DBMET00703 | |
| 0.039 | 0.113 | 0.062 | Cathepsin E inhibitor | 0.062 0.038 DBMET00785 0.054 0.05 DBMET00703 0.057 0.046 DBMET00704 0.058 0.044 DBMET03314 0.058 0.044 DBMET03315 | DBMET00785 | |
| 0.035 | 0.109 | 0.301 | Antineoplastic antibiotic | 0.149 0.031 DBMET00637 0.301 0.009 DBMET03316 | DBMET03316 | |
| 0.015 | 0.089 | 0.14 | Integrin antagonist | 0.14 0.011 DBMET00703 | DBMET00703 | |
| 0.051 | 0.125 | 0.079 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.079 0.04 DBMET00785 | DBMET00785 | |
| 0.025 | 0.101 | 0.049 | Plasmepsin II inhibitor | 0.045 0.022 DBMET00785 0.049 0.019 DBMET00704 | DBMET00704 | |
| 0.031 | 0.106 | 0.054 | Cathepsin D inhibitor | 0.054 0.038 DBMET00785 | DBMET00785 | |
| 0.014 | 0.09 | 0.049 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.049 0.012 DBMET00637 | DBMET00637 | |
| 0.029 | 0.105 | 0.098 | Purinergic P2X2 antagonist | 0.098 0.031 DBMET00704 0.057 0.054 DBMET03314 0.057 0.054 DBMET03315 | DBMET00704 | |
| 0.01 | 0.086 | 0.149 | AMPA 2 receptor antagonist | 0.149 0.004 DBMET00703 | DBMET00703 | |
| 0.014 | 0.091 | 0.027 | Calcium-sensing receptor agonist | 0.027 0.017 DBMET00703 | DBMET00703 | |
| 0.024 | 0.102 | 0.042 | Nicotinic receptor alpha3 subunit antagonist | 0.042 0.033 DBMET00785 | DBMET00785 | |
| 0.03 | 0.109 | 0.041 | Dipeptidyl peptidase IV inhibitor | 0.041 0.039 DBMET00785 | DBMET00785 | |
| 0.02 | 0.099 | 0.06 | Guanylate cyclase inhibitor | 0.058 0.013 DBMET00637 0.06 0.011 DBMET03316 | DBMET03316 | |
| 0.028 | 0.107 | 0.039 | Integrin alpha1beta1 antagonist | 0.039 0.024 DBMET00703 | DBMET00703 | |
| 0.017 | 0.097 | 0.053 | Carbonic anhydrase I stimulant | 0.053 0.014 DBMET00703 | DBMET00703 | |
| 0.022 | 0.102 | 0.076 | Antibiotic Aminoglycoside-like | 0.076 0.005 DBMET03316 | DBMET03316 | |
| 0.007 | 0.087 | 0.51 | Cholecystokinin A agonist | 0.51 0.002 DBMET03313 0.416 0.002 DBMET00784 | DBMET03313 | |
| 0.023 | 0.104 | 0.037 | Neurokinin 2 agonist | 0.037 0.035 DBMET00785 | DBMET00785 | |
| 0.135 | 0.216 | 0.229 | Prostaglandin dehydrogenase inhibitor | 0.229 0.139 DBMET00637 | DBMET00637 | |
| 0.064 | 0.146 | 0.125 | Interleukin 1 beta converting enzyme inhibitor | 0.106 0.05 DBMET00785 0.125 0.031 DBMET00637 0.108 0.047 DBMET00703 | DBMET00637 | |
| 0.015 | 0.097 | 0.063 | Opioid delta receptor agonist | 0.063 0.009 DBMET00785 0.039 0.02 DBMET00703 0.043 0.017 DBMET00704 0.032 0.031 DBMET03314 0.032 0.031 DBMET03315 | DBMET00785 | |
| 0.068 | 0.15 | 0.118 | Beta amyloid protein antagonist | 0.098 0.093 DBMET00785 0.112 0.076 DBMET00703 0.118 0.07 DBMET00704 | DBMET00704 | |
| 0.016 | 0.098 | 0.062 | Estradiol 17 beta-dehydrogenase inhibitor | 0.062 0.019 DBMET00637 | DBMET00637 | |
| 0.075 | 0.159 | 0.41 | Electron transport complex I inhibitor | 0.41 0.004 DBMET00637 0.112 0.059 DBMET00703 0.127 0.038 DBMET00704 0.142 0.025 DBMET03314 0.153 0.019 DBMET03316 0.142 0.025 DBMET03315 | DBMET00637 | |
| 0.011 | 0.096 | 0.035 | Estradiol 17 beta-dehydrogenase 2 inhibitor | 0.035 0.025 DBMET00637 | DBMET00637 | |
| 0.047 | 0.133 | 0.065 | Transcription factor RelA inhibitor | 0.065 0.041 DBMET00637 0.064 0.042 DBMET00704 | DBMET00637 | |
| 0.064 | 0.15 | 0.084 | Hematopoietic | 0.084 0.062 DBMET00703 | DBMET00703 | |
| 0.065 | 0.152 | 0.09 | CC chemokine 5 receptor agonist | 0.083 0.053 DBMET00785 0.09 0.036 DBMET00637 | DBMET00637 | |
| 0.013 | 0.1 | 0.04 | Nicotinic acid receptor agonist | 0.04 0.021 DBMET00637 | DBMET00637 | |
| 0.099 | 0.186 | 0.339 | Dual specificity phosphatase inhibitor | 0.339 0.023 DBMET03313 0.269 0.034 DBMET00784 | DBMET03313 | |
| 0.04 | 0.127 | 0.076 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.06 0.044 DBMET00785 0.076 0.022 DBMET00637 | DBMET00637 | |
| 0.018 | 0.106 | 0.044 | Endothelin-converting enzyme inhibitor | 0.044 0.035 DBMET00703 | DBMET00703 | |
| 0.038 | 0.126 | 0.065 | Elastase 1 inhibitor | 0.065 0.054 DBMET00637 | DBMET00637 | |
| 0.034 | 0.122 | 0.05 | Dipeptidyl peptidase inhibitor | 0.05 0.043 DBMET00785 | DBMET00785 | |
| 0.103 | 0.192 | 0.178 | Interleukin 6 antagonist | 0.167 0.067 DBMET00785 0.178 0.057 DBMET00703 0.165 0.07 DBMET00704 0.139 0.107 DBMET03314 0.173 0.061 DBMET03316 0.139 0.107 DBMET03315 | DBMET00703 | |
| 0.015 | 0.104 | 0.068 | Carbonic anhydrase VII inhibitor | 0.068 0.016 DBMET00637 0.047 0.031 DBMET03316 | DBMET00637 | |
| 0.083 | 0.174 | 0.15 | Transcription factor STAT6 inhibitor | 0.15 0.023 DBMET00785 0.108 0.085 DBMET00637 0.119 0.062 DBMET00704 0.133 0.04 DBMET03314 0.133 0.04 DBMET03315 | DBMET00785 | |
| 0.103 | 0.194 | 0.134 | Pregnane X receptor agonist | 0.134 0.088 DBMET00637 0.128 0.105 DBMET03314 0.128 0.105 DBMET03315 | DBMET00637 | |
| 0.089 | 0.181 | 0.185 | DNA repair enzyme inhibitor | 0.11 0.095 DBMET00785 0.109 0.1 DBMET00637 0.12 0.073 DBMET00703 0.11 0.095 DBMET00704 0.107 0.103 DBMET03314 0.185 0.012 DBMET03316 0.107 0.103 DBMET03315 | DBMET03316 | |
| 0.047 | 0.139 | 0.507 | Antiadrenergic | 0.507 0.005 DBMET03314 0.507 0.005 DBMET03315 | DBMET03315 | |
| 0.045 | 0.139 | 0.503 | Adrenaline antagonist | 0.503 0.005 DBMET03314 0.503 0.005 DBMET03315 | DBMET03315 | |
| 0.113 | 0.207 | 0.208 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.208 0.085 DBMET00785 0.169 0.12 DBMET00704 | DBMET00785 | |
| 0.018 | 0.114 | 0.128 | Beta tubulin antagonist | 0.049 0.047 DBMET00785 0.119 0.018 DBMET00637 0.109 0.02 DBMET00703 0.128 0.016 DBMET00704 | DBMET00704 | |
| 0.069 | 0.165 | 0.132 | Nav1.6 sodium channel blocker | 0.132 0.078 DBMET00785 0.117 0.101 DBMET00704 | DBMET00785 | |
| 0.02 | 0.117 | 0.094 | Opioid agonist | 0.094 0.014 DBMET00785 0.057 0.032 DBMET00703 0.061 0.029 DBMET00704 | DBMET00785 | |
| 0.03 | 0.127 | 0.067 | Androgen agonist | 0.067 0.033 DBMET00637 | DBMET00637 | |
| 0.023 | 0.12 | 0.04 | Plasmin inhibitor | 0.04 0.038 DBMET00785 | DBMET00785 | |
| 0.032 | 0.129 | 0.055 | Heme oxygenase inhibitor | 0.055 0.009 DBMET00637 | DBMET00637 | |
| 0.066 | 0.164 | 0.122 | Interleukin 12 antagonist | 0.093 0.066 DBMET00703 0.122 0.027 DBMET03316 | DBMET03316 | |
| 0.005 | 0.103 | 0.015 | KiSS-1 receptor antagonist | 0.015 0.014 DBMET00637 | DBMET00637 | |
| 0.115 | 0.214 | 0.164 | Death-associated protein kinase 2 inhibitor | 0.161 0.084 DBMET00785 0.164 0.077 DBMET00637 0.138 0.137 DBMET00704 | DBMET00637 | |
| 0.007 | 0.106 | 0.021 | Kainate receptor 3 antagonist | 0.021 0.009 DBMET00703 | DBMET00703 | |
| 0.03 | 0.129 | 0.066 | Nitric oxide donor | 0.066 0.039 DBMET03316 | DBMET03316 | |
| 0.116 | 0.215 | 0.177 | Catenin beta inhibitor | 0.152 0.102 DBMET00785 0.177 0.056 DBMET00703 0.147 0.112 DBMET00704 | DBMET00703 | |
| 0.038 | 0.139 | 0.067 | Kallikrein 1 inhibitor | 0.067 0.026 DBMET00785 0.055 0.042 DBMET00704 0.054 0.044 DBMET03314 0.054 0.044 DBMET03315 | DBMET00785 | |
| 0.039 | 0.141 | 0.137 | Analgesic, opioid | 0.137 0.018 DBMET00785 0.083 0.044 DBMET00637 0.09 0.037 DBMET00703 0.091 0.036 DBMET00704 0.067 0.066 DBMET03314 0.067 0.066 DBMET03315 | DBMET00785 | |
| 0.013 | 0.115 | 0.031 | Cholesterol ester transfer protein antagonist | 0.031 0.022 DBMET00637 | DBMET00637 | |
| 0.029 | 0.132 | 0.051 | Cytokine production stimulant | 0.046 0.042 DBMET03314 0.051 0.027 DBMET03316 0.046 0.042 DBMET03315 | DBMET03316 | |
| 0.012 | 0.116 | 0.071 | NMDA 2D receptor antagonist | 0.071 0.005 DBMET03313 0.032 0.014 DBMET00703 0.061 0.005 DBMET00784 | DBMET03313 | |
| 0.021 | 0.125 | 0.045 | Dihydroorotase inhibitor | 0.04 0.038 DBMET00785 0.045 0.03 DBMET00637 | DBMET00637 | |
| 0.015 | 0.12 | 0.034 | Melanocortin 1 antagonist | 0.034 0.03 DBMET00785 | DBMET00785 | |
| 0.012 | 0.117 | 0.081 | AMPA receptor agonist | 0.039 0.019 DBMET00785 0.044 0.013 DBMET00637 0.081 0.004 DBMET00703 | DBMET00703 | |
| 0.159 | 0.264 | 0.412 | DNA directed DNA polymerase inhibitor | 0.412 0.111 DBMET00637 | DBMET00637 | |
| 0.015 | 0.122 | 0.031 | Motilin receptor antagonist | 0.031 0.014 DBMET00785 0.025 0.024 DBMET00704 | DBMET00785 | |
| 0.038 | 0.144 | 0.18 | Topoisomerase II alpha inhibitor | 0.18 0.018 DBMET03316 | DBMET03316 | |
| 0.019 | 0.126 | 0.038 | Integrin alpha2 antagonist | 0.038 0.024 DBMET00703 | DBMET00703 | |
| 0.014 | 0.123 | 0.054 | Somatostatin 1 antagonist | 0.047 0.022 DBMET00785 0.054 0.018 DBMET03314 0.054 0.018 DBMET03315 | DBMET03315 | |
| 0.064 | 0.173 | 0.12 | Caspase 3 inhibitor | 0.109 0.077 DBMET00785 0.12 0.059 DBMET00637 0.111 0.073 DBMET00703 | DBMET00637 | |
| 0.084 | 0.196 | 0.337 | Dual specificity phosphatase 3 inhibitor | 0.337 0.023 DBMET03313 0.276 0.033 DBMET00784 | DBMET03313 | |
| 0.116 | 0.23 | 0.578 | Cardiotonic | 0.19 0.129 DBMET00703 0.578 0.009 DBMET03314 0.578 0.009 DBMET03315 | DBMET03315 | |
| 0.018 | 0.132 | 0.049 | Metalloproteinase-3 inhibitor | 0.049 0.034 DBMET00703 | DBMET00703 | |
| 0.032 | 0.147 | 0.073 | Transcription factor AP-1 inhibitor | 0.068 0.033 DBMET00637 0.073 0.027 DBMET03316 | DBMET03316 | |
| 0.023 | 0.138 | 0.055 | Glutamate (mGluR) agonist | 0.055 0.05 DBMET00703 | DBMET00703 | |
| 0.088 | 0.203 | 0.137 | Heat shock protein 90 alpha antagonist | 0.137 0.102 DBMET00785 0.137 0.102 DBMET00637 0.13 0.112 DBMET00704 | DBMET00637 | |
| 0.152 | 0.268 | 0.329 | DNA polymerase beta inhibitor | 0.329 0.15 DBMET00637 | DBMET00637 | |
| 0.013 | 0.129 | 0.047 | Cathepsin L2 inhibitor | 0.047 0.024 DBMET00785 | DBMET00785 | |
| 0.023 | 0.139 | 0.045 | Microtubule stabilization | 0.045 0.035 DBMET03316 | DBMET03316 | |
| 0.13 | 0.249 | 0.32 | Transcription factor STAT3 inhibitor | 0.32 0.044 DBMET00785 0.229 0.102 DBMET00637 0.274 0.067 DBMET00703 0.314 0.047 DBMET00704 0.196 0.14 DBMET03314 0.196 0.14 DBMET03315 | DBMET00785 | |
| 0.008 | 0.127 | 0.031 | Calpain 1 inhibitor | 0.031 0.029 DBMET00785 | DBMET00785 | |
| 0.006 | 0.127 | 0.037 | Somatostatin 5 antagonist | 0.032 0.022 DBMET00785 0.037 0.02 DBMET03314 0.037 0.02 DBMET03315 | DBMET03315 | |
| 0.059 | 0.18 | 0.411 | Beta glucuronidase inhibitor | 0.128 0.038 DBMET00637 0.411 0.004 DBMET03316 | DBMET03316 | |
| 0.042 | 0.164 | 0.07 | Histone deacetylase SIRT3 inhibitor | 0.07 0.027 DBMET00785 | DBMET00785 | |
| 0.141 | 0.263 | 0.216 | 5 Hydroxytryptamine 3E antagonist | 0.216 0.041 DBMET00785 0.188 0.086 DBMET00637 0.169 0.138 DBMET00704 0.174 0.122 DBMET03314 0.174 0.122 DBMET03315 | DBMET00785 | |
| 0.048 | 0.172 | 0.211 | Cell adhesion molecule inhibitor | 0.211 0.009 DBMET00703 0.1 0.035 DBMET03316 | DBMET00703 | |
| 0.002 | 0.126 | 0.013 | Antibiotic Macrolide-like | 0.013 0.011 DBMET03316 | DBMET03316 | |
| 0.005 | 0.13 | 0.025 | Alpha 2a adrenoreceptor agonist | 0.025 0.006 DBMET03314 0.025 0.006 DBMET03315 | DBMET03315 | |
| 0.036 | 0.16 | 0.102 | Thrombin inhibitor | 0.071 0.053 DBMET00785 0.102 0.025 DBMET03313 0.093 0.03 DBMET00784 | DBMET03313 | |
| 0.069 | 0.194 | 0.142 | Acetylcholine release stimulant | 0.142 0.022 DBMET00637 0.104 0.079 DBMET00704 0.125 0.04 DBMET03316 0.12 0.049 DBMET00784 | DBMET00637 | |
| 0.014 | 0.14 | 0.058 | Alpha 1d adrenoreceptor agonist | 0.035 0.032 DBMET00637 0.058 0.012 DBMET03314 0.058 0.012 DBMET03315 | DBMET03315 | |
| 0.016 | 0.144 | 0.088 | Carbonic anhydrase inhibitor | 0.088 0.031 DBMET03313 0.057 0.049 DBMET00784 | DBMET03313 | |
| 0.006 | 0.134 | 0.026 | Kainate receptor 5 antagonist | 0.026 0.011 DBMET00703 | DBMET00703 | |
| 0.036 | 0.163 | 0.155 | Androgen antagonist | 0.155 0.021 DBMET00637 | DBMET00637 | |
| 0.034 | 0.163 | 0.127 | CYP2A6 inhibitor | 0.127 0.024 DBMET00785 0.1 0.036 DBMET00637 0.076 0.052 DBMET00704 | DBMET00785 | |
| 0.011 | 0.142 | 0.033 | Peptide deformylase inhibitor | 0.033 0.018 DBMET00637 | DBMET00637 | |
| 0.02 | 0.151 | 0.158 | NMDA 2 receptor antagonist | 0.086 0.04 DBMET00785 0.098 0.033 DBMET00703 0.158 0.015 DBMET03314 0.158 0.015 DBMET03315 | DBMET03315 | |
| 0.111 | 0.243 | 0.676 | Cyclic AMP phosphodiesterase inhibitor | 0.191 0.1 DBMET00785 0.458 0.01 DBMET00637 0.272 0.054 DBMET00703 0.225 0.077 DBMET00704 0.237 0.07 DBMET03314 0.676 0.004 DBMET03316 0.237 0.07 DBMET03315 | DBMET03316 | |
| 0.021 | 0.153 | 0.059 | Prolyl endopeptidase inhibitor | 0.059 0.025 DBMET00785 0.054 0.031 DBMET00637 | DBMET00785 | |
| 0.046 | 0.178 | 0.247 | MAO inhibitor | 0.247 0.028 DBMET00785 0.136 0.067 DBMET00637 0.105 0.086 DBMET00703 0.245 0.029 DBMET00704 | DBMET00785 | |
| 0.03 | 0.163 | 0.07 | Nicotinic alpha4beta2 receptor antagonist | 0.07 0.062 DBMET00785 | DBMET00785 | |
| 0.02 | 0.154 | 0.109 | Protein 50S ribosomal subunit inhibitor | 0.054 0.036 DBMET03314 0.109 0.011 DBMET03316 0.054 0.036 DBMET03315 | DBMET03316 | |
| 0.007 | 0.142 | 0.029 | Kainate receptor 4 antagonist | 0.029 0.014 DBMET00703 | DBMET00703 | |
| 0.035 | 0.171 | 0.256 | MAO A inhibitor | 0.256 0.02 DBMET00785 0.094 0.069 DBMET00637 0.256 0.02 DBMET00704 | DBMET00704 | |
| 0.015 | 0.152 | 0.033 | Somatostatin 5 agonist | 0.033 0.027 DBMET00785 | DBMET00785 | |
| 0.096 | 0.234 | 0.154 | 3C-like protease (Human coronavirus) inhibitor | 0.145 0.111 DBMET00785 0.154 0.095 DBMET00637 0.146 0.109 DBMET00704 | DBMET00637 | |
| 0.052 | 0.192 | 0.251 | Tubulin antagonist | 0.183 0.043 DBMET00637 0.225 0.03 DBMET00703 0.251 0.025 DBMET00704 0.12 0.08 DBMET03314 0.107 0.094 DBMET00784 0.12 0.08 DBMET03315 | DBMET00704 | |
| 0.016 | 0.157 | 0.083 | Leukocyte elastase inhibitor | 0.075 0.014 DBMET03313 0.083 0.012 DBMET00784 | DBMET00784 | |
| 0.022 | 0.165 | 0.053 | Dopamine uptake inhibitor | 0.053 0.045 DBMET00785 | DBMET00785 | |
| 0.024 | 0.168 | 0.095 | Dopamine agonist | 0.095 0.029 DBMET00785 0.074 0.041 DBMET00704 | DBMET00785 | |
| 0.021 | 0.165 | 0.037 | Adenosine uptake inhibitor | 0.035 0.022 DBMET00785 0.035 0.022 DBMET00637 0.037 0.018 DBMET00704 | DBMET00704 | |
| 0.006 | 0.151 | 0.041 | Leukotriene A4 hydrolase inhibitor | 0.041 0.024 DBMET00703 | DBMET00703 | |
| 0.008 | 0.155 | 0.08 | Carbonic anhydrase XII inhibitor | 0.08 0.025 DBMET03316 | DBMET03316 | |
| 0.016 | 0.165 | 0.054 | Cathepsin L inhibitor | 0.054 0.045 DBMET00785 | DBMET00785 | |
| 0.053 | 0.202 | 0.15 | Histone deacetylase class III inhibitor | 0.15 0.044 DBMET00785 0.12 0.07 DBMET00703 0.107 0.082 DBMET00704 | DBMET00785 | |
| 0.069 | 0.22 | 0.247 | Neurotrophic factor | 0.166 0.046 DBMET00785 0.247 0.013 DBMET00637 0.149 0.06 DBMET00703 0.156 0.054 DBMET00704 0.157 0.053 DBMET03314 0.175 0.041 DBMET03316 0.157 0.053 DBMET03315 | DBMET00637 | |
| 0.004 | 0.156 | 0.054 | Estrone sulfatase inhibitor | 0.054 0.007 DBMET03313 0.038 0.009 DBMET00784 | DBMET03313 | |
| 0.046 | 0.199 | 0.069 | Vanilloid 4 agonist | 0.069 0.067 DBMET00785 0.069 0.068 DBMET00637 | DBMET00637 | |
| 0.025 | 0.178 | 0.041 | CF transmembrane conductance regulator antagonist | 0.041 0.024 DBMET00637 | DBMET00637 | |
| 0.016 | 0.169 | 0.054 | Histamine H2 receptor agonist | 0.054 0.018 DBMET00785 | DBMET00785 | |
| 0.013 | 0.168 | 0.027 | Thrombin receptor antagonist | 0.027 0.022 DBMET00785 | DBMET00785 | |
| 0.086 | 0.24 | 0.431 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.431 0.031 DBMET00637 0.167 0.124 DBMET00704 0.15 0.143 DBMET03314 0.15 0.143 DBMET03315 | DBMET00637 | |
| 0.009 | 0.165 | 0.021 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.021 0.013 DBMET00637 | DBMET00637 | |
| 0.006 | 0.164 | 0.03 | Endothelial nitric-oxide synthase inhibitor | 0.03 0.022 DBMET00785 | DBMET00785 | |
| 0.008 | 0.166 | 0.031 | Methionyl aminopeptidase 1 inhibitor | 0.03 0.026 DBMET00785 0.031 0.024 DBMET03314 0.031 0.024 DBMET03315 | DBMET03315 | |
| 0.049 | 0.213 | 0.121 | Protein kinase C zeta inhibitor | 0.121 0.032 DBMET00785 0.096 0.056 DBMET00703 0.114 0.036 DBMET00704 | DBMET00785 | |
| 0.013 | 0.18 | 0.063 | Aromatase inhibitor | 0.063 0.04 DBMET00637 | DBMET00637 | |
| 0.025 | 0.192 | 0.091 | Factor IXa inhibitor | 0.091 0.012 DBMET03313 0.083 0.015 DBMET03314 0.085 0.014 DBMET03316 0.079 0.016 DBMET00784 0.083 0.015 DBMET03315 | DBMET03313 | |
| 0.072 | 0.242 | 0.124 | Heat shock protein 90 antagonist | 0.119 0.115 DBMET00785 0.124 0.107 DBMET00704 | DBMET00704 | |
| 0.022 | 0.192 | 0.133 | MAO B inhibitor | 0.133 0.044 DBMET00785 0.128 0.046 DBMET00704 | DBMET00785 | |
| 0.057 | 0.229 | 0.14 | Cytokine production inhibitor | 0.109 0.101 DBMET00785 0.133 0.077 DBMET00637 0.14 0.07 DBMET00703 0.129 0.081 DBMET00704 | DBMET00703 | |
| 0.02 | 0.193 | 0.24 | 5 Hydroxytryptamine 2A agonist | 0.223 0.004 DBMET00785 0.107 0.012 DBMET00703 0.24 0.004 DBMET00704 0.153 0.005 DBMET03314 0.153 0.005 DBMET03315 | DBMET00704 | |
| 0.05 | 0.225 | 0.098 | Interleukin 5 antagonist | 0.098 0.044 DBMET03314 0.098 0.044 DBMET03315 | DBMET03315 | |
| 0.182 | 0.36 | 0.822 | Antiinflammatory | 0.28 0.235 DBMET03313 0.524 0.078 DBMET00637 0.259 0.257 DBMET00703 0.822 0.013 DBMET03316 | DBMET03316 | |
| 0.122 | 0.299 | 0.424 | Immunomodulator | 0.214 0.148 DBMET00703 0.424 0.038 DBMET03316 | DBMET03316 | |
| 0.056 | 0.235 | 0.171 | Phosphodiesterase 6D inhibitor | 0.11 0.036 DBMET00637 0.171 0.006 DBMET03316 | DBMET03316 | |
| 0.042 | 0.222 | 0.068 | Prolactin release inhibitor | 0.065 0.034 DBMET00785 0.068 0.026 DBMET00703 | DBMET00703 | |
| 0.12 | 0.3 | 0.253 | Neuropeptide Y2 antagonist | 0.253 0.053 DBMET00785 0.195 0.128 DBMET00637 0.193 0.133 DBMET00703 0.215 0.096 DBMET00704 0.251 0.055 DBMET03314 0.251 0.055 DBMET03315 | DBMET00785 | |
| 0.04 | 0.221 | 0.253 | Topoisomerase II inhibitor | 0.253 0.024 DBMET03316 | DBMET03316 | |
| 0.2 | 0.382 | 0.322 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.272 0.253 DBMET00785 0.322 0.185 DBMET00637 | DBMET00637 | |
| 0.056 | 0.238 | 0.082 | 3C-Like protease (SARS coronavirus) inhibitor | 0.082 0.063 DBMET00785 | DBMET00785 | |
| 0.154 | 0.35 | 0.702 | Apoptosis agonist | 0.414 0.107 DBMET00785 0.57 0.056 DBMET00637 0.426 0.102 DBMET00703 0.466 0.085 DBMET00704 0.337 0.147 DBMET03314 0.702 0.03 DBMET03316 0.337 0.147 DBMET03315 | DBMET03316 | |
| 0.099 | 0.295 | 0.146 | CC chemokine 6 receptor antagonist | 0.146 0.029 DBMET03316 | DBMET03316 | |
| 0.03 | 0.228 | 0.252 | Topoisomerase I inhibitor | 0.087 0.083 DBMET00637 0.252 0.017 DBMET03316 | DBMET03316 | |
| 0.015 | 0.214 | 0.059 | Dopamine transporter inhibitor | 0.059 0.025 DBMET00785 0.046 0.036 DBMET00704 | DBMET00785 | |
| 0.028 | 0.227 | 0.057 | Glucosylceramidase inhibitor | 0.057 0.035 DBMET03314 0.057 0.035 DBMET03315 | DBMET03315 | |
| 0.009 | 0.209 | 0.048 | Factor Xa inhibitor | 0.048 0.03 DBMET03313 | DBMET03313 | |
| 0.042 | 0.243 | 0.103 | Factor XII inhibitor | 0.089 0.051 DBMET00785 0.103 0.035 DBMET00703 0.089 0.05 DBMET00704 | DBMET00703 | |
| 0.042 | 0.249 | 0.163 | Protein kinase C gamma inhibitor | 0.129 0.045 DBMET00785 0.104 0.07 DBMET00703 0.118 0.054 DBMET00704 0.163 0.025 DBMET03314 0.163 0.025 DBMET03315 | DBMET03315 | |
| 0.037 | 0.244 | 0.09 | Chymotrypsin inhibitor | 0.09 0.043 DBMET00785 0.081 0.053 DBMET00637 0.078 0.057 DBMET00703 0.074 0.063 DBMET00704 | DBMET00785 | |
| 0.054 | 0.262 | 0.238 | Antibacterial (Helicobacter pylori) | 0.116 0.087 DBMET00785 0.238 0.014 DBMET00637 0.122 0.079 DBMET00703 0.12 0.081 DBMET00704 0.141 0.054 DBMET03314 0.154 0.043 DBMET03316 0.141 0.054 DBMET03315 | DBMET00637 | |
| 0.064 | 0.274 | 0.14 | Amyloid beta precursor protein antagonist | 0.14 0.113 DBMET00703 0.137 0.117 DBMET00704 | DBMET00703 | |
| 0.019 | 0.229 | 0.064 | Amidase inhibitor | 0.064 0.058 DBMET00637 | DBMET00637 | |
| 0.015 | 0.226 | 0.05 | Histamine H1 receptor agonist | 0.05 0.018 DBMET00785 | DBMET00785 | |
| 0.004 | 0.216 | 0.015 | Dipeptidyl peptidase IX inhibitor | 0.015 0.011 DBMET00785 | DBMET00785 | |
| 0.108 | 0.322 | 0.326 | Transcription factor STAT inhibitor | 0.326 0.043 DBMET00785 0.208 0.127 DBMET00637 0.247 0.089 DBMET00703 0.297 0.057 DBMET00704 0.205 0.131 DBMET03314 0.205 0.131 DBMET03315 | DBMET00785 | |
| 0.068 | 0.293 | 0.182 | P-glycoprotein inhibitor | 0.155 0.11 DBMET00637 0.179 0.081 DBMET00703 0.182 0.078 DBMET00704 0.178 0.082 DBMET03316 | DBMET00704 | |
| 0.085 | 0.312 | 0.237 | 5 Hydroxytryptamine 1E antagonist | 0.237 0.089 DBMET00785 0.221 0.107 DBMET00637 0.236 0.09 DBMET00704 0.185 0.148 DBMET03314 0.185 0.148 DBMET03315 | DBMET00785 | |
| 0.074 | 0.303 | 0.232 | Tumour necrosis factor antagonist | 0.15 0.1 DBMET00785 0.2 0.054 DBMET00703 0.232 0.037 DBMET00704 | DBMET00704 | |
| 0.045 | 0.276 | 0.162 | Interleukin 1b antagonist | 0.162 0.032 DBMET00637 0.114 0.067 DBMET03316 | DBMET00637 | |
| 0.015 | 0.247 | 0.071 | TRPA1 antagonist | 0.071 0.032 DBMET00637 | DBMET00637 | |
| 0.013 | 0.252 | 0.062 | Acetylcholine M5 receptor antagonist | 0.062 0.039 DBMET03314 0.062 0.039 DBMET03315 | DBMET03315 | |
| 0.122 | 0.363 | 0.397 | Caspase 3 stimulant | 0.259 0.104 DBMET00785 0.383 0.049 DBMET00637 0.312 0.073 DBMET00703 0.355 0.058 DBMET00704 0.214 0.15 DBMET03314 0.397 0.046 DBMET03316 0.214 0.15 DBMET03315 | DBMET03316 | |
| 0.014 | 0.263 | 0.073 | 5 Hydroxytryptamine 2B agonist | 0.073 0.005 DBMET00785 0.067 0.007 DBMET00704 0.059 0.009 DBMET03314 0.059 0.009 DBMET03315 | DBMET00785 | |
| 0.059 | 0.312 | 0.156 | Neuropeptide Y1 antagonist | 0.156 0.057 DBMET00785 0.151 0.063 DBMET00704 | DBMET00785 | |
| 0.03 | 0.288 | 0.168 | Glutamate receptor antagonist | 0.168 0.039 DBMET00703 | DBMET00703 | |
| 0.087 | 0.347 | 0.206 | Histone acetyltransferase inhibitor | 0.206 0.06 DBMET00637 | DBMET00637 | |
| 0.02 | 0.281 | 0.11 | Protein kinase C iota inhibitor | 0.11 0.016 DBMET00785 0.059 0.041 DBMET00703 0.085 0.023 DBMET00704 | DBMET00785 | |
| 0.015 | 0.285 | 0.045 | Phenylethanolamine N methyltransferase inhibitor | 0.045 0.02 DBMET00785 | DBMET00785 | |
| 0.005 | 0.275 | 0.046 | Dopamine D2 agonist | 0.046 0.03 DBMET03313 | DBMET03313 | |
| 0.013 | 0.285 | 0.033 | Purinergic P2Y2 antagonist | 0.033 0.024 DBMET03313 0.031 0.028 DBMET00784 | DBMET03313 | |
| 0.015 | 0.291 | 0.082 | HIV-1 reverse transcriptase inhibitor | 0.082 0.041 DBMET00637 | DBMET00637 | |
| 0.019 | 0.299 | 0.058 | 5 Hydroxytryptamine 7 agonist | 0.058 0.035 DBMET00704 | DBMET00704 | |
| 0.045 | 0.327 | 0.188 | Interleukin 1 antagonist | 0.188 0.038 DBMET00637 | DBMET00637 | |
| 0.039 | 0.325 | 0.185 | Aryl hydrocarbon receptor agonist | 0.185 0.111 DBMET00637 | DBMET00637 | |
| 0.033 | 0.324 | 0.11 | Breast cancer-resistant protein inhibitor | 0.088 0.068 DBMET00703 0.11 0.046 DBMET00704 0.102 0.053 DBMET00784 | DBMET00704 | |
| 0.009 | 0.306 | 0.036 | Histone deacetylase 7 inhibitor | 0.036 0.026 DBMET00637 | DBMET00637 | |
| 0.047 | 0.355 | 0.083 | T cell inhibitor | 0.083 0.055 DBMET03316 | DBMET03316 | |
| 0.088 | 0.399 | 0.256 | Transcription factor inhibitor | 0.256 0.183 DBMET00637 | DBMET00637 | |
| 0.023 | 0.339 | 0.075 | Histone deacetylase stimulant | 0.075 0.049 DBMET03316 | DBMET03316 | |
| 0.023 | 0.339 | 0.075 | Histone deacetylase SIRT1 stimulant | 0.075 0.049 DBMET03316 | DBMET03316 | |
| 0.024 | 0.344 | 0.078 | Caspase 7 inhibitor | 0.078 0.065 DBMET00637 | DBMET00637 | |
| 0.03 | 0.358 | 0.198 | Multidrug resistance-associated protein 1 inhibitor | 0.19 0.013 DBMET03313 0.101 0.076 DBMET00703 0.093 0.092 DBMET00704 0.109 0.064 DBMET03316 0.198 0.011 DBMET00784 | DBMET00784 | |
| 0.013 | 0.344 | 0.032 | Toll-Like receptor 4 agonist | 0.027 0.017 DBMET03313 0.032 0.009 DBMET03316 0.031 0.011 DBMET00784 | DBMET03316 | |
| 0.015 | 0.351 | 0.072 | Adrenaline uptake inhibitor | 0.072 0.033 DBMET00785 | DBMET00785 | |
| 0.059 | 0.411 | 0.278 | Calpain 2 inhibitor | 0.257 0.145 DBMET00785 0.278 0.129 DBMET00637 0.197 0.19 DBMET00704 0.248 0.151 DBMET03314 0.248 0.151 DBMET03315 | DBMET00637 | |
| 0.018 | 0.372 | 0.099 | Alpha 2 adrenoreceptor antagonist | 0.099 0.048 DBMET03314 0.099 0.048 DBMET03315 | DBMET03315 | |
| 0.044 | 0.4 | 0.247 | Antimitotic | 0.237 0.065 DBMET00703 0.247 0.061 DBMET00704 0.153 0.119 DBMET03314 0.153 0.118 DBMET00784 0.153 0.119 DBMET03315 | DBMET00704 | |
| 0.009 | 0.37 | 0.038 | Histone deacetylase 9 inhibitor | 0.038 0.029 DBMET00637 | DBMET00637 | |
| 0.009 | 0.374 | 0.089 | Alpha 1 adrenoreceptor agonist | 0.089 0.02 DBMET03314 0.089 0.02 DBMET03315 | DBMET03315 | |
| 0.028 | 0.394 | 0.126 | Cytidine deaminase inhibitor | 0.126 0.095 DBMET00637 | DBMET00637 | |
| 0.03 | 0.41 | 0.11 | Falcipain inhibitor | 0.094 0.059 DBMET00785 0.085 0.068 DBMET00704 0.11 0.049 DBMET03316 | DBMET03316 | |
| 0.082 | 0.462 | 0.224 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.224 0.131 DBMET00785 0.223 0.132 DBMET00704 | DBMET00785 | |
| 0.03 | 0.412 | 0.107 | Falcipain 2 inhibitor | 0.091 0.059 DBMET00785 0.082 0.067 DBMET00704 0.107 0.048 DBMET03316 | DBMET03316 | |
| 0.024 | 0.419 | 0.205 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | 0.205 0.049 DBMET00785 0.175 0.062 DBMET00704 | DBMET00785 | |
| 0.004 | 0.399 | 0.11 | 5 Hydroxytryptamine 2 agonist | 0.11 0.008 DBMET00785 0.103 0.009 DBMET00704 0.083 0.014 DBMET03314 0.083 0.014 DBMET03315 | DBMET00785 | |
| 0.067 | 0.464 | 0.224 | Growth factor agonist | 0.224 0.044 DBMET00637 | DBMET00637 | |
| 0.015 | 0.414 | 0.099 | Alpha 2a adrenoreceptor antagonist | 0.099 0.037 DBMET03314 0.099 0.037 DBMET03315 | DBMET03315 | |
| 0.025 | 0.436 | 0.148 | Alpha 2b adrenoreceptor antagonist | 0.095 0.079 DBMET00785 0.121 0.057 DBMET00704 0.148 0.039 DBMET03314 0.148 0.039 DBMET03315 | DBMET03315 | |
| 0.024 | 0.436 | 0.068 | Phosphodiesterase VI inhibitor | 0.068 0.067 DBMET03316 | DBMET03316 | |
| 0.022 | 0.441 | 0.104 | Alpha 2c adrenoreceptor antagonist | 0.104 0.063 DBMET03314 0.104 0.063 DBMET03315 | DBMET03315 | |
| 0.035 | 0.496 | 0.117 | Toll-Like receptor 3 antagonist | 0.117 0.031 DBMET03314 0.117 0.031 DBMET03315 | DBMET03315 | |
| 0.006 | 0.479 | 0.053 | Acetyl-CoA transferase inhibitor | 0.053 0.037 DBMET00637 | DBMET00637 | |
| 0.004 | 0.49 | 0.036 | Dipeptidyl peptidase I inhibitor | 0.036 0.015 DBMET00785 | DBMET00785 | |
| 0.008 | 0.495 | 0.082 | Elastase inhibitor | 0.082 0.015 DBMET03313 0.077 0.018 DBMET00784 | DBMET03313 | |
| 0.033 | 0.531 | 0.6 | Tumour necrosis factor alpha release inhibitor | 0.236 0.082 DBMET00637 0.298 0.054 DBMET00703 0.271 0.065 DBMET00704 0.6 0.007 DBMET03316 | DBMET03316 | |
| 0.009 | 0.512 | 0.074 | Protein kinase A inhibitor | 0.074 0.066 DBMET00785 | DBMET00785 | |
| 0.013 | 0.519 | 0.139 | 5 Hydroxytryptamine 2B antagonist | 0.125 0.056 DBMET00785 0.139 0.046 DBMET00704 | DBMET00704 | |
| 0.005 | 0.532 | 0.159 | NMDA 2B receptor antagonist | 0.159 0.008 DBMET03313 0.096 0.016 DBMET00784 | DBMET03313 | |
| 0.005 | 0.549 | 0.089 | 5 Hydroxytryptamine 2C antagonist | 0.077 0.064 DBMET00785 0.089 0.053 DBMET00704 | DBMET00704 | |
| 0.013 | 0.574 | 0.099 | DNA intercalator | 0.099 0.075 DBMET03316 | DBMET03316 | |
| 0.008 | 0.574 | 0.045 | Baculoviral IAP repeat-containing protein inhibitor | 0.045 0.035 DBMET00785 | DBMET00785 | |
| 0.032 | 0.609 | 0.328 | Angiogenesis inhibitor | 0.283 0.102 DBMET03313 0.202 0.167 DBMET03316 0.328 0.08 DBMET00784 | DBMET00784 | |
| 0.004 | 0.592 | 0.034 | Factor XI inhibitor | 0.034 0.024 DBMET03313 0.034 0.023 DBMET00784 | DBMET00784 | |
| 0.019 | 0.612 | 0.187 | Platelet aggregation inhibitor | 0.187 0.091 DBMET00703 | DBMET00703 | |
| 0.004 | 0.707 | 0.096 | Alpha 1a adrenoreceptor agonist | 0.096 0.003 DBMET03314 0.096 0.003 DBMET03315 | DBMET03315 | |
| 0.004 | 0.724 | 0.348 | 5 Hydroxytryptamine 1F antagonist | 0.348 0.005 DBMET00785 0.219 0.009 DBMET00704 | DBMET00785 | |
| 0.003 | 0.74 | 0.145 | 5 Hydroxytryptamine 2C agonist | 0.145 0.005 DBMET00785 0.101 0.008 DBMET00704 0.074 0.013 DBMET03314 0.074 0.013 DBMET03315 | DBMET00785 | |
| 0.004 | 0.808 | 0.25 | 5 Hydroxytryptamine agonist | 0.25 0.011 DBMET00785 0.168 0.018 DBMET00704 0.194 0.015 DBMET03314 0.194 0.015 DBMET03315 | DBMET00785 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |